var data={"title":"Anesthesia for labor and delivery in high-risk heart disease: Specific lesions","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Anesthesia for labor and delivery in high-risk heart disease: Specific lesions</div><dl id=\"topicContributors\"><dt><span> </span>Author:</dt><dd><a href=\"https://www.uptodate.com/contents/anesthesia-for-labor-and-delivery-in-high-risk-heart-disease-specific-lesions/contributors\" class=\"contributor contributor_credentials\">Katherine W Arendt, MD</a></dd><dt><span> </span>Section Editors:</dt><dd><a href=\"https://www.uptodate.com/contents/anesthesia-for-labor-and-delivery-in-high-risk-heart-disease-specific-lesions/contributors\" class=\"contributor contributor_credentials\">David L Hepner, MD</a></dd><dd><a href=\"https://www.uptodate.com/contents/anesthesia-for-labor-and-delivery-in-high-risk-heart-disease-specific-lesions/contributors\" class=\"contributor contributor_credentials\">Heidi M Connolly, MD, FASE</a></dd><dd><a href=\"https://www.uptodate.com/contents/anesthesia-for-labor-and-delivery-in-high-risk-heart-disease-specific-lesions/contributors\" class=\"contributor contributor_credentials\">Jonathan B Mark, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/anesthesia-for-labor-and-delivery-in-high-risk-heart-disease-specific-lesions/contributors\" class=\"contributor contributor_credentials\">Nancy A Nussmeier, MD, FAHA</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/anesthesia-for-labor-and-delivery-in-high-risk-heart-disease-specific-lesions/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Dec 16, 2017.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H87110730\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Anesthetic management of the pregnant woman with high-risk cardiovascular disease requires an understanding of:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The patient&rsquo;s baseline cardiac anatomy and pathophysiology</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>How the patient&rsquo;s cardiac disease will be affected by the physiologic changes associated with pregnancy, labor, and delivery </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>How the patient&rsquo;s cardiac disease will be affected by analgesic and anesthetic techniques </p><p/><p>Ideally, a team of providers (cardiologist, obstetrician, and anesthesiologist) will develop an individualized management plan antepartum. Interdisciplinary communication and preparation are critically important, since peripartum obstetric and cardiac complications may require urgent intervention.</p><p>This topic will discuss the anesthetic management of the obstetric patient with acquired or congenital heart lesions that are symptomatic and severe, emphasizing methods to minimize peripartum risk while providing optimal anesthetic care. Our approach to each cardiac lesion is based upon physiologic principles and clinical experience. In patients with complex cardiac pathology or multiple lesions that may have opposing hemodynamic impact (eg, combined mitral stenosis and mitral regurgitation), the multidisciplinary care team including anesthesiologist, cardiologist, and obstetrician should determine which lesion is most likely to lead to hemodynamic deterioration and intervene as needed. </p><p>General considerations in the anesthetic management of the obstetric patient with acquired or congenital heart disease are discussed separately, including the benefits of epidural analgesia during labor and vaginal delivery, as well as options for neuraxial or general anesthesia for cesarean delivery. (See <a href=\"topic.htm?path=anesthesia-for-labor-and-delivery-in-high-risk-heart-disease-general-considerations\" class=\"medical medical_review\">&quot;Anesthesia for labor and delivery in high-risk heart disease: General considerations&quot;</a>.) The medical management of pregnant women with acquired or congenital heart disease is also reviewed separately. (See <a href=\"topic.htm?path=acquired-heart-disease-and-pregnancy\" class=\"medical medical_review\">&quot;Acquired heart disease and pregnancy&quot;</a> and <a href=\"topic.htm?path=pregnancy-and-valve-disease\" class=\"medical medical_review\">&quot;Pregnancy and valve disease&quot;</a> and <a href=\"topic.htm?path=pregnancy-in-women-with-congenital-heart-disease-general-principles\" class=\"medical medical_review\">&quot;Pregnancy in women with congenital heart disease: General principles&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H909975868\"><span class=\"h1\">MONITORING</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>(See <a href=\"topic.htm?path=anesthesia-for-labor-and-delivery-in-high-risk-heart-disease-general-considerations#H1188687597\" class=\"medical medical_review\">&quot;Anesthesia for labor and delivery in high-risk heart disease: General considerations&quot;, section on 'Monitoring'</a>.)</p><p class=\"headingAnchor\" id=\"H1410255201\"><span class=\"h1\">ANALGESIA AND ANESTHESIA FOR LABOR AND DELIVERY</span></p><p class=\"headingAnchor\" id=\"H909976159\"><span class=\"h2\">Neuraxial analgesia for labor</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>(See <a href=\"topic.htm?path=anesthesia-for-labor-and-delivery-in-high-risk-heart-disease-general-considerations#H77919293\" class=\"medical medical_review\">&quot;Anesthesia for labor and delivery in high-risk heart disease: General considerations&quot;, section on 'Neuraxial analgesia for labor'</a>.)</p><p class=\"headingAnchor\" id=\"H1008493904\"><span class=\"h2\">Neuraxial anesthesia for cesarean delivery</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>(See <a href=\"topic.htm?path=anesthesia-for-labor-and-delivery-in-high-risk-heart-disease-general-considerations#H734055903\" class=\"medical medical_review\">&quot;Anesthesia for labor and delivery in high-risk heart disease: General considerations&quot;, section on 'Neuraxial anesthesia for cesarean delivery'</a>.)</p><p class=\"headingAnchor\" id=\"H909976649\"><span class=\"h2\">General anesthesia for cesarean delivery</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>(See <a href=\"topic.htm?path=anesthesia-for-labor-and-delivery-in-high-risk-heart-disease-general-considerations#H734055828\" class=\"medical medical_review\">&quot;Anesthesia for labor and delivery in high-risk heart disease: General considerations&quot;, section on 'General anesthesia technique for cesarean delivery'</a>.) </p><p class=\"headingAnchor\" id=\"H909976308\"><span class=\"h1\">AORTIC STENOSIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>A summary of key points for management of aortic stenosis (AS) is provided in the table (<a href=\"image.htm?imageKey=ANEST%2F97424\" class=\"graphic graphic_table graphicRef97424 \">table 1</a>).</p><p class=\"headingAnchor\" id=\"H3436077736\"><span class=\"h2\">Pathophysiology and hemodynamic management</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Severe AS causes obstruction of left ventricular (LV) outflow resulting in LV pressure overload, concentric hypertrophy, and diastolic dysfunction that often leads to decreased stroke volume (SV) and cardiac output (CO). Key hemodynamic goals to preserve adequate CO include maintaining sinus rhythm with a left atrial contraction (ie, atrial &quot;kick&quot;), normal heart rate (ie, absence of tachycardia or bradycardia), and adequate preload. Hypotension is avoided, since the resulting reduction in coronary perfusion can lead to subendocardial ischemia and ventricular arrhythmias. </p><p>Systolic blood pressure (BP) is maintained &gt;100 mmHg, mean arterial BP &gt;70 mmHg, or both within 20 percent of baseline. Hypotension due to presumed decrease in systemic vascular resistance (SVR) is treated with <a href=\"topic.htm?path=phenylephrine-drug-information\" class=\"drug drug_general\">phenylephrine</a> administered as boluses 40 to 100 mcg, or an infusion 0.1 to 2 <span class=\"nowrap\">mcg/kg</span> per minute. <a href=\"topic.htm?path=norepinephrine-noradrenaline-drug-information\" class=\"drug drug_general\">Norepinephrine</a> may be administered in the event that phenylephrine is ineffective (<a href=\"image.htm?imageKey=ANEST%2F96387\" class=\"graphic graphic_table graphicRef96387 \">table 2</a>).</p><p>If onset of atrial fibrillation is associated with hemodynamic deterioration (eg, hypotension, evidence of cardiogenic shock) or fetal compromise, immediate synchronized cardioversion to restore sinus rhythm may be necessary. Pregnancy is not a contraindication to direct current cardioversion. For this reason, we place external defibrillator pads as part of intrapartum preparation of AS patients with a history of poorly-tolerated tachyarrhythmias. During cardioversion attempts, BP is maintained with alpha adrenergic agonists (eg, <a href=\"topic.htm?path=phenylephrine-drug-information\" class=\"drug drug_general\">phenylephrine</a>). (See <a href=\"topic.htm?path=atrial-fibrillation-cardioversion-to-sinus-rhythm\" class=\"medical medical_review\">&quot;Atrial fibrillation: Cardioversion to sinus rhythm&quot;</a>.)</p><p>In uncomplicated laboring patients, intravascular volume (preload) is maintained by allowing intake of moderate amounts of clear fluids throughout labor, as per the American Society of Anesthesiologists and American Congress of Obstetricians and Gynecologists guidelines [<a href=\"https://www.uptodate.com/contents/anesthesia-for-labor-and-delivery-in-high-risk-heart-disease-specific-lesions/abstract/1,2\" class=\"abstract_t\">1,2</a>]. If a laboring patient no longer desires liquids, intravenous administration of maintenance fluid is initiated at 1 <span class=\"nowrap\">mL/kg</span> per hour, and titrated according to clinical assessment of the patient&rsquo;s volume status and the hemodynamic response to any fluid boluses.</p><p>Peripartum hemorrhage, if it occurs, should be rapidly treated with fluid and blood resuscitation, as appropriate, and uterotonic drugs (eg, oxytocin, <a href=\"topic.htm?path=carboprost-tromethamine-drug-information\" class=\"drug drug_general\">carboprost tromethamine</a>, <a href=\"topic.htm?path=methylergonovine-drug-information\" class=\"drug drug_general\">methylergonovine</a>, <a href=\"topic.htm?path=misoprostol-drug-information\" class=\"drug drug_general\">misoprostol</a>) if bleeding is related to atony. <a href=\"topic.htm?path=phenylephrine-drug-information\" class=\"drug drug_general\">Phenylephrine</a> should also be administered as a temporizing measure to reverse arterial hypotension. (See <a href=\"topic.htm?path=anesthesia-for-the-patient-with-peripartum-hemorrhage\" class=\"medical medical_review\">&quot;Anesthesia for the patient with peripartum hemorrhage&quot;</a> and <a href=\"topic.htm?path=postpartum-hemorrhage-medical-and-minimally-invasive-management#H1819760813\" class=\"medical medical_review\">&quot;Postpartum hemorrhage: Medical and minimally invasive management&quot;, section on 'Administer additional uterotonic drugs'</a>.)</p><p>Further details regarding perioperative and hemodynamic management of patients with AS are provided elsewhere. (See <a href=\"topic.htm?path=anesthesia-for-noncardiac-surgery-in-patients-with-aortic-or-mitral-valve-disease#H440052400\" class=\"medical medical_review\">&quot;Anesthesia for noncardiac surgery in patients with aortic or mitral valve disease&quot;, section on 'Aortic stenosis'</a>.) </p><p class=\"headingAnchor\" id=\"H125403349\"><span class=\"h2\">Anesthetic techniques</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The following anesthetic considerations apply to patients with severe or symptomatic AS: </p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Neuraxial anesthesia for labor </strong>&ndash; We suggest a labor epidural if feasible. The epidural should be placed early in labor, prior to significant catecholamine release caused by labor pain. The specific technique used for the test dose should be carefully considered. (See <a href=\"topic.htm?path=anesthesia-for-labor-and-delivery-in-high-risk-heart-disease-general-considerations#H77919293\" class=\"medical medical_review\">&quot;Anesthesia for labor and delivery in high-risk heart disease: General considerations&quot;, section on 'Neuraxial analgesia for labor'</a> and <a href=\"topic.htm?path=anesthesia-for-labor-and-delivery-in-high-risk-heart-disease-general-considerations#H1059864016\" class=\"medical medical_review\">&quot;Anesthesia for labor and delivery in high-risk heart disease: General considerations&quot;, section on 'Test dose administration'</a>.).</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Neuraxial anesthesia for cesarean delivery </strong>&ndash; A very slowly titrated epidural anesthetic or a low-dose sequential combined spinal-epidural is reasonable after an intra-arterial catheter has been inserted for continuous monitoring of BP. (See <a href=\"topic.htm?path=anesthesia-for-labor-and-delivery-in-high-risk-heart-disease-general-considerations#H734055903\" class=\"medical medical_review\">&quot;Anesthesia for labor and delivery in high-risk heart disease: General considerations&quot;, section on 'Neuraxial anesthesia for cesarean delivery'</a>.)</p><p/><p class=\"bulletIndent1\">Avoid spinal anesthesia in patients with AS because the rapid onset of a sympathectomy and consequent decrease in SVR may cause life-threatening hypotension.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>General anesthesia for cesarean delivery</strong> &ndash; An intra-arterial catheter is inserted for continuous BP monitoring and rapid detection and treatment of hypotension.</p><p/><p class=\"bulletIndent1\">Induction agents and doses are selected to reduce the likelihood of severe hypotension (eg, titrate <a href=\"topic.htm?path=propofol-drug-information\" class=\"drug drug_general\">propofol</a> to effect, rather than administering a high dose of propofol), while establishing an anesthetic depth adequate to minimize sympathetic stimulation and resultant tachycardia during laryngoscopy and intubation. (See <a href=\"topic.htm?path=anesthesia-for-labor-and-delivery-in-high-risk-heart-disease-general-considerations#H734055828\" class=\"medical medical_review\">&quot;Anesthesia for labor and delivery in high-risk heart disease: General considerations&quot;, section on 'General anesthesia technique for cesarean delivery'</a>.)</p><p/><p class=\"bulletIndent1\">Hypotension is treated urgently by infusion of intravenous fluid, <a href=\"topic.htm?path=phenylephrine-drug-information\" class=\"drug drug_general\">phenylephrine</a>, <span class=\"nowrap\">and/or</span> <a href=\"topic.htm?path=norepinephrine-noradrenaline-drug-information\" class=\"drug drug_general\">norepinephrine</a> if needed, all of which should be prepared and immediately available. (See <a href=\"topic.htm?path=anesthesia-for-labor-and-delivery-in-high-risk-heart-disease-general-considerations#H734055903\" class=\"medical medical_review\">&quot;Anesthesia for labor and delivery in high-risk heart disease: General considerations&quot;, section on 'Neuraxial anesthesia for cesarean delivery'</a>.)</p><p/><p class=\"bulletIndent1\">If tachycardia occurs, it should be treated promptly by deepening general anesthesia <span class=\"nowrap\">and/or</span> administering beta blockers (eg, <a href=\"topic.htm?path=esmolol-drug-information\" class=\"drug drug_general\">esmolol</a>, <a href=\"topic.htm?path=labetalol-drug-information\" class=\"drug drug_general\">labetalol</a>, or <a href=\"topic.htm?path=metoprolol-drug-information\" class=\"drug drug_general\">metoprolol</a>) to control heart rate. Some clinicians use <a href=\"topic.htm?path=remifentanil-drug-information\" class=\"drug drug_general\">remifentanil</a>, an &ldquo;ultra-short&rdquo;-acting opioid, as a supplemental agent during and after induction to provide maternal hemodynamic stability (eg, avoid tachycardia) without risk of causing prolonged neonatal respiratory depression [<a href=\"https://www.uptodate.com/contents/anesthesia-for-labor-and-delivery-in-high-risk-heart-disease-specific-lesions/abstract/3,4\" class=\"abstract_t\">3,4</a>].</p><p/><p class=\"headingAnchor\" id=\"H909976928\"><span class=\"h1\">MITRAL STENOSIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>A summary of key points for management of mitral stenosis (MS) is provided in the table (<a href=\"image.htm?imageKey=ANEST%2F97435\" class=\"graphic graphic_table graphicRef97435 \">table 3</a>).</p><p class=\"headingAnchor\" id=\"H2311120143\"><span class=\"h2\">Pathophysiology and hemodynamic management</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Severe MS causes impaired left ventricular (LV) filling due to obstruction of left atrial (LA) outflow. LA pressure, pulmonary artery pressure (PAP), and pulmonary artery wedge pressure (PAWP) are increased. Patients with chronic MS typically have increased pulmonary vascular resistance (PVR) and pulmonary hypertension. </p><p>Key hemodynamic goals to preserve adequate cardiac output (CO) include maintaining a normal heart rate. Tachycardia is avoided to allow adequate time for diastolic LV filling through the stenotic mitral valve. Severe bradycardia is also avoided, since this reduces cardiac output when a stenotic mitral valve limits LV filling and stroke volume. Sinus rhythm is optimal, although patients with MS often develop persistent or permanent atrial fibrillation because of left atrial dilation. These patients require meticulous heart rate control to improve left ventricular filling.</p><p>Patients with atrial fibrillation require anticoagulation due to the high risk of thromboembolism that mitral stenosis confers. Management of anticoagulation in pregnancy is reviewed separately. (See <a href=\"topic.htm?path=use-of-anticoagulants-during-pregnancy-and-postpartum\" class=\"medical medical_review\">&quot;Use of anticoagulants during pregnancy and postpartum&quot;</a>.)</p><p>Aggressive fluid administration is avoided, as this may result in pulmonary congestion in a peripartum patient with severe MS, particularly in patients with associated preeclampsia. Patients are at highest risk for pulmonary edema immediately after delivery, because of aorto-caval decompression and autotransfusion from the contracting evacuated uterus. Dehydration is also avoided, since adequate preload is needed to maintain left ventricular filling. Intake of moderate amounts of clear fluids is allowed for uncomplicated laboring patients, as per American Society of Anesthesiologists and American Congress of Obstetricians and Gynecologists guidelines [<a href=\"https://www.uptodate.com/contents/anesthesia-for-labor-and-delivery-in-high-risk-heart-disease-specific-lesions/abstract/1,2\" class=\"abstract_t\">1,2</a>]. Additional fluid administration to treat presumed hypovolemia warrants careful monitoring for signs and symptoms of pulmonary congestion.</p><p>Systolic BP is maintained &gt;100 mmHg, mean arterial BP &gt;70 mmHg, or both within 20 percent of baseline. Hypotension due to presumed decrease in systemic vascular resistance (SVR) is treated with <a href=\"topic.htm?path=phenylephrine-drug-information\" class=\"drug drug_general\">phenylephrine</a>, administered as boluses (40 to 100 mcg), or an infusion (0.1 to 2 <span class=\"nowrap\">mcg/kg</span> per minute). <a href=\"topic.htm?path=norepinephrine-noradrenaline-drug-information\" class=\"drug drug_general\">Norepinephrine</a> may be administered if phenylephrine is ineffective (<a href=\"image.htm?imageKey=ANEST%2F96387\" class=\"graphic graphic_table graphicRef96387 \">table 2</a>).</p><p>Hypoxemia <span class=\"nowrap\">and/or</span> hypercarbia that may further increase PVR and exacerbate pulmonary hypertension are avoided by administering supplemental oxygen and avoiding over-sedation.</p><p>Further details regarding perioperative and hemodynamic management of patients with MS are provided elsewhere. (See <a href=\"topic.htm?path=anesthesia-for-noncardiac-surgery-in-patients-with-aortic-or-mitral-valve-disease#H1804652926\" class=\"medical medical_review\">&quot;Anesthesia for noncardiac surgery in patients with aortic or mitral valve disease&quot;, section on 'Mitral stenosis'</a>.) </p><p class=\"headingAnchor\" id=\"H19381528\"><span class=\"h2\">Anesthetic techniques</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The following considerations apply to patients with severe or symptomatic MS (see <a href=\"topic.htm?path=pregnancy-in-women-with-mitral-stenosis\" class=\"medical medical_review\">&quot;Pregnancy in women with mitral stenosis&quot;</a>):</p><p>An intra-arterial catheter for continuous blood pressure monitoring is inserted prior to either neuraxial anesthesia or analgesia, or induction of general anesthesia, so that hypotension can be immediately detected and treated. Initial treatment with <a href=\"topic.htm?path=phenylephrine-drug-information\" class=\"drug drug_general\">phenylephrine</a> is recommended. If phenylephrine is ineffective, <a href=\"topic.htm?path=norepinephrine-noradrenaline-drug-information\" class=\"drug drug_general\">norepinephrine</a> may be used to provide systemic vasoconstriction and inotropic support while avoiding an increase in heart rate (<a href=\"image.htm?imageKey=ANEST%2F96387\" class=\"graphic graphic_table graphicRef96387 \">table 2</a>). Avoid vasoactive agents likely to cause tachycardia (eg, <a href=\"topic.htm?path=dopamine-drug-information\" class=\"drug drug_general\">dopamine</a>, <a href=\"topic.htm?path=dobutamine-drug-information\" class=\"drug drug_general\">dobutamine</a>, <a href=\"topic.htm?path=epinephrine-adrenaline-drug-information\" class=\"drug drug_general\">epinephrine</a>).</p><p>External defibrillator pads are placed on the patient for rapid cardioversion if atrial fibrillation develops and the patient is tachycardic and hypotensive.</p><p class=\"headingAnchor\" id=\"H437688507\"><span class=\"h3\">Neuraxial analgesia for labor</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>We suggest a labor epidural if feasible. In order to avoid tachycardia, the epidural should be placed early in labor, prior to significant pain-related catecholamine release. The specific technique used for administration of the test dose should be carefully considered to avoid tachycardia. Subsequently, the analgesic block should be sufficiently dense to avoid any sympathetic stimulation from even mild labor pain. (See <a href=\"topic.htm?path=anesthesia-for-labor-and-delivery-in-high-risk-heart-disease-general-considerations#H77919293\" class=\"medical medical_review\">&quot;Anesthesia for labor and delivery in high-risk heart disease: General considerations&quot;, section on 'Neuraxial analgesia for labor'</a> and <a href=\"topic.htm?path=anesthesia-for-labor-and-delivery-in-high-risk-heart-disease-general-considerations#H1059864016\" class=\"medical medical_review\">&quot;Anesthesia for labor and delivery in high-risk heart disease: General considerations&quot;, section on 'Test dose administration'</a>.)</p><p class=\"headingAnchor\" id=\"H437688515\"><span class=\"h3\">Neuraxial anesthesia for cesarean delivery</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>A very slowly titrated epidural anesthetic or a low-dose sequential combined spinal-epidural is reasonable after an intra-arterial catheter has been inserted for continuous monitoring of BP. (See <a href=\"topic.htm?path=anesthesia-for-labor-and-delivery-in-high-risk-heart-disease-general-considerations#H734055903\" class=\"medical medical_review\">&quot;Anesthesia for labor and delivery in high-risk heart disease: General considerations&quot;, section on 'Neuraxial anesthesia for cesarean delivery'</a>.)</p><p class=\"bulletIndent1\">Avoid spinal anesthesia in patients with severe MS. The rapid onset of a sympathectomy and consequent venodilation and decrease in preload may cause life-threatening hypotension.</p><p/><p class=\"headingAnchor\" id=\"H437688534\"><span class=\"h3\">General anesthesia for cesarean delivery</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>If general anesthesia is needed for cesarean delivery, an intra-arterial catheter is inserted prior to induction.</p><p>Use of beta blockers to avoid or treat tachycardia during induction of anesthesia, laryngoscopy, and intubation is reasonable. Avoid induction agents that cause tachycardia (eg, <a href=\"topic.htm?path=ketamine-drug-information\" class=\"drug drug_general\">ketamine</a>) or decrease SVR (eg, high doses of <a href=\"topic.htm?path=propofol-drug-information\" class=\"drug drug_general\">propofol</a>). Some clinicians use <a href=\"topic.htm?path=remifentanil-drug-information\" class=\"drug drug_general\">remifentanil</a>, an &ldquo;ultra-short&rdquo;-acting opioid, as a supplemental agent during and after induction to provide maternal hemodynamic stability without risk of inducing prolonged neonatal depression [<a href=\"https://www.uptodate.com/contents/anesthesia-for-labor-and-delivery-in-high-risk-heart-disease-specific-lesions/abstract/3,4\" class=\"abstract_t\">3,4</a>].</p><p>Avoid hypoxemia and hypercarbia during induction, controlled ventilation, and emergence from general anesthesia. Avoid <a href=\"topic.htm?path=nitrous-oxide-drug-information\" class=\"drug drug_general\">nitrous oxide</a> because it can further increase PVR. Do not administer prostaglandin F2 alpha therapy (carboprost&nbsp;<a href=\"topic.htm?path=tromethamine-tham-united-states-not-available-drug-information\" class=\"drug drug_general\">tromethamine</a>) to counteract uterine atony because it significantly increases PVR. (See <a href=\"topic.htm?path=anesthesia-for-labor-and-delivery-in-high-risk-heart-disease-general-considerations#H734055828\" class=\"medical medical_review\">&quot;Anesthesia for labor and delivery in high-risk heart disease: General considerations&quot;, section on 'General anesthesia technique for cesarean delivery'</a>.)</p><p class=\"headingAnchor\" id=\"H301149167\"><span class=\"h2\">Pulmonary edema risk in the post-partum period</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Patients with severe MS are at risk for rapid onset pulmonary edema (&ldquo;flash&rdquo; pulmonary edema) after birth because the uterus is lifted off the vena cava immediately after delivery, allowing blood from the lower body to return rapidly to the heart. Simultaneously, the uterus begins to contract and squeeze the blood from its venous sinuses into the inferior vena cava. The result is a sudden increase in preload. Theoretically, the increased venous capacitance caused by the sympathetic blockade with neuraxial anesthesia helps to accommodate the autotransfusion that occurs immediately after delivery. (See <a href=\"topic.htm?path=anesthesia-for-labor-and-delivery-in-high-risk-heart-disease-general-considerations#H734055903\" class=\"medical medical_review\">&quot;Anesthesia for labor and delivery in high-risk heart disease: General considerations&quot;, section on 'Neuraxial anesthesia for cesarean delivery'</a>.)</p><p>Flash pulmonary edema in the awake patient may present as acute dyspnea, hypoxemia, and coughing. If the awake patient has only mild signs and symptoms of pulmonary congestion, treatment may include positioning the bed in the most head-up position possible and administering 100 percent oxygen via mask ventilation with as much positive end expiratory pressure as the patient can tolerate. However, if severe symptoms are present, intravenous administration of a diuretic (eg, <a href=\"topic.htm?path=furosemide-drug-information\" class=\"drug drug_general\">furosemide</a>) is suggested. If symptoms persist, the anesthesiologist must be prepared to induce general anesthesia, intubate the trachea, and use positive pressure mechanical ventilation.</p><p><a href=\"topic.htm?path=nitroglycerin-glyceryl-trinitrate-drug-information\" class=\"drug drug_general\">Nitroglycerin</a> infusion is avoided in the immediate postpartum period since it can significantly increase obstetric hemorrhage due to uterine atony.</p><p class=\"headingAnchor\" id=\"H855740842\"><span class=\"h1\">MITRAL OR AORTIC REGURGITATION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>A summary of key points for management of aortic regurgitation (AR) or mitral regurgitation (MR) is provided in the table (<a href=\"image.htm?imageKey=ANEST%2F97437\" class=\"graphic graphic_table graphicRef97437 \">table 4</a>). </p><p class=\"headingAnchor\" id=\"H1844349936\"><span class=\"h2\">Pathophysiology and hemodynamic management</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Patients with moderate degrees of AR or MR usually tolerate pregnancy well because the normal decrease in systemic vascular resistance (SVR) during pregnancy improves cardiac output in these conditions. However, patients with chronic severe AR or MR who have left ventricular dilation <span class=\"nowrap\">and/or</span> decreased myocardial contractility, as well as increased pulmonary artery pressure or symptomatic congestive heart failure may develop progressive symptoms of heart failure during pregnancy or delivery.</p><p>Key hemodynamic goals, particularly in AR, include maintaining a relatively low SVR and a relatively fast heart rate (HR) of 80 to 100 beats per minute to decrease regurgitant flow and increase forward cardiac output. Bradycardia is particularly detrimental in AR because it increases regurgitation, thereby reducing cardiac output. </p><p>Sinus rhythm is optimal, but many patients with chronic MR have permanent atrial fibrillation due to left atrial dilation. (See <a href=\"topic.htm?path=pregnancy-in-women-with-a-bicuspid-aortic-valve#H14\" class=\"medical medical_review\">&quot;Pregnancy in women with a bicuspid aortic valve&quot;, section on 'Bicuspid aortic regurgitation'</a> and <a href=\"topic.htm?path=acquired-heart-disease-and-pregnancy\" class=\"medical medical_review\">&quot;Acquired heart disease and pregnancy&quot;</a>.)</p><p>Intake of moderate amounts of clear fluids is allowed in uncomplicated laboring patients, as per American Society of Anesthesiologists and American Congress of Obstetricians and Gynecologists guidelines to prevent dehydration and maintain preload throughout labor [<a href=\"https://www.uptodate.com/contents/anesthesia-for-labor-and-delivery-in-high-risk-heart-disease-specific-lesions/abstract/1,2\" class=\"abstract_t\">1,2</a>]. If a laboring patient no longer desires liquids, intravenous administration of maintenance fluid is initiated at 1 <span class=\"nowrap\">mL/kg</span> per hour and titrated according to clinical assessment of the patient&rsquo;s volume status. Aggressive fluid administration is avoided, as this may result in pulmonary congestion.</p><p>An acute increase in SVR is typically identified by a rise in systemic blood pressure (BP) and is treated to avoid regurgitant flow and decreased forward flow. Careful afterload reduction with regional anesthesia is beneficial. <a href=\"topic.htm?path=nitroglycerin-glyceryl-trinitrate-drug-information\" class=\"drug drug_general\">Nitroglycerin</a> or <a href=\"topic.htm?path=nitroprusside-drug-information\" class=\"drug drug_general\">nitroprusside</a> can be administered to decrease SVR (<a href=\"image.htm?imageKey=ANEST%2F96387\" class=\"graphic graphic_table graphicRef96387 \">table 2</a>). However, in postpartum patients, these agents should be avoided because they cause uterine relaxation and may increase risk of obstetric hemorrhage.</p><p>Mild hypotension is treated with agents that increase contractility (eg, <a href=\"topic.htm?path=ephedrine-systemic-drug-information\" class=\"drug drug_general\">ephedrine</a>, a sympathomimetic agent with mixed alpha and beta adrenergic effects, administered in 5 to 10 mg increments). Continuous infusion of agents that increase stroke volume via a combination of peripheral dilation and enhanced contractility (eg, a phosphodiesterase inhibitor such as <a href=\"topic.htm?path=milrinone-drug-information\" class=\"drug drug_general\">milrinone</a> <span class=\"nowrap\">and/or</span> selected beta-adrenergic inotropic agents such as <a href=\"topic.htm?path=dobutamine-drug-information\" class=\"drug drug_general\">dobutamine</a>) may be beneficial (<a href=\"image.htm?imageKey=ANEST%2F96387\" class=\"graphic graphic_table graphicRef96387 \">table 2</a>). However, in a hypotensive patient, maintenance of adequate BP may require administration of <a href=\"topic.htm?path=epinephrine-adrenaline-drug-information\" class=\"drug drug_general\">epinephrine</a> or <a href=\"topic.htm?path=norepinephrine-noradrenaline-drug-information\" class=\"drug drug_general\">norepinephrine</a> in combination with milrinone or dobutamine (<a href=\"image.htm?imageKey=ANEST%2F96387\" class=\"graphic graphic_table graphicRef96387 \">table 2</a>).</p><p>Hypoxemia <span class=\"nowrap\">and/or</span> hypercarbia may exacerbate pre-existing pulmonary hypertension, and should be promptly treated with supplemental oxygen. Oversedation is avoided. &#160;</p><p>Further details regarding perioperative and hemodynamic management of patients with AR or MR are provided elsewhere. (See <a href=\"topic.htm?path=anesthesia-for-noncardiac-surgery-in-patients-with-aortic-or-mitral-valve-disease#H440052487\" class=\"medical medical_review\">&quot;Anesthesia for noncardiac surgery in patients with aortic or mitral valve disease&quot;, section on 'Aortic regurgitation'</a> and <a href=\"topic.htm?path=anesthesia-for-noncardiac-surgery-in-patients-with-aortic-or-mitral-valve-disease#H46808580\" class=\"medical medical_review\">&quot;Anesthesia for noncardiac surgery in patients with aortic or mitral valve disease&quot;, section on 'Mitral regurgitation'</a>.)</p><p class=\"headingAnchor\" id=\"H136552329\"><span class=\"h2\">Anesthetic techniques</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The following considerations apply to patients with severe or symptomatic MR or AR (see <a href=\"topic.htm?path=noncardiac-surgery-in-patients-with-mitral-or-aortic-regurgitation\" class=\"medical medical_review\">&quot;Noncardiac surgery in patients with mitral or aortic regurgitation&quot;</a>):</p><p class=\"headingAnchor\" id=\"H375330840\"><span class=\"h3\">Neuraxial analgesia for labor</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>An epidural is strongly preferred for labor and delivery. The specific technique for the test dose should be carefully considered. The epidural should be placed early in labor prior to significant catecholamine release from pain. Subsequently, the analgesic block should be sufficiently dense to avoid any sympathetic stimulation from even mild labor pain. (See <a href=\"topic.htm?path=anesthesia-for-labor-and-delivery-in-high-risk-heart-disease-general-considerations#H77919293\" class=\"medical medical_review\">&quot;Anesthesia for labor and delivery in high-risk heart disease: General considerations&quot;, section on 'Neuraxial analgesia for labor'</a> and <a href=\"topic.htm?path=anesthesia-for-labor-and-delivery-in-high-risk-heart-disease-general-considerations#H1059864016\" class=\"medical medical_review\">&quot;Anesthesia for labor and delivery in high-risk heart disease: General considerations&quot;, section on 'Test dose administration'</a>.)</p><p>In patients with symptomatic heart failure, an intra-arterial catheter is inserted for continuous BP monitoring prior to neuraxial intervention.</p><p class=\"headingAnchor\" id=\"H87110803\"><span class=\"h3\">Neuraxial anesthesia for cesarean delivery</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Patients with MR or AR usually tolerate both spinal and epidural anesthesia well, because the decrease in afterload lessens the regurgitant volume. <a href=\"topic.htm?path=ephedrine-systemic-drug-information\" class=\"drug drug_general\">Ephedrine</a> may be used to maintain systemic BP, as well as maintain the HR above 70 to 80 beats per minute.</p><p>Although hypertension should be avoided in patients with AR or MR, bolus doses of <a href=\"topic.htm?path=ephedrine-systemic-drug-information\" class=\"drug drug_general\">ephedrine</a> and a <a href=\"topic.htm?path=phenylephrine-drug-information\" class=\"drug drug_general\">phenylephrine</a> infusion should be prepared in advance, prior to administration of the spinal anesthetic, in order to treat the potentially rapid development of hypotension due to sympathectomy. (See <a href=\"topic.htm?path=anesthesia-for-labor-and-delivery-in-high-risk-heart-disease-general-considerations#H734055903\" class=\"medical medical_review\">&quot;Anesthesia for labor and delivery in high-risk heart disease: General considerations&quot;, section on 'Neuraxial anesthesia for cesarean delivery'</a>.)</p><p class=\"headingAnchor\" id=\"H890497247\"><span class=\"h3\">General anesthesia for cesarean delivery</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>If general anesthesia is needed for cesarean delivery, an intra-arterial catheter is inserted in patients with severe MR or severe AR.</p><p>Careful titration of <a href=\"topic.htm?path=propofol-drug-information\" class=\"drug drug_general\">propofol</a> is preferred for induction, because of its ability to reduce SVR. Also, adequate doses of induction and maintenance anesthetic agents are necessary to avoid increased BP due to sympathetic stimulation during tracheal intubation, surgical incision, and the subsequent surgical procedure.</p><p>For patients with heart failure who are intubated and anesthetized, transesophageal echocardiography (TEE) is the best method to assess volume status during general anesthesia and has the added benefit of monitoring of MR or AR severity and ventricular function. (See <a href=\"topic.htm?path=intraoperative-transesophageal-echocardiography-for-noncardiac-surgery#H128384691\" class=\"medical medical_review\">&quot;Intraoperative transesophageal echocardiography for noncardiac surgery&quot;, section on 'Volume status'</a> and <a href=\"topic.htm?path=intraoperative-transesophageal-echocardiography-for-noncardiac-surgery#H168991298\" class=\"medical medical_review\">&quot;Intraoperative transesophageal echocardiography for noncardiac surgery&quot;, section on 'Ventricular function'</a> and <a href=\"topic.htm?path=intraoperative-transesophageal-echocardiography-for-noncardiac-surgery#H168991316\" class=\"medical medical_review\">&quot;Intraoperative transesophageal echocardiography for noncardiac surgery&quot;, section on 'Valvular structure and function'</a>.)</p><p class=\"headingAnchor\" id=\"H890497254\"><span class=\"h2\">Acute mitral or aortic regurgitation</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Patients with acute onset of severe MR or AR (eg, due to acute endocarditis) are unstable, and will require tracheal intubation, controlled ventilation, and inotropic <span class=\"nowrap\">and/or</span> vasodilator support, even as preparations are made for emergency cesarean delivery. These patients also typically require emergency cardiac surgery, which may be timed with cesarean delivery, depending on gestational age at presentation.</p><p>Phosphodiesterase inhibitor inodilator agents (eg, <a href=\"topic.htm?path=milrinone-drug-information\" class=\"drug drug_general\">milrinone</a> (<a href=\"image.htm?imageKey=ANEST%2F96387\" class=\"graphic graphic_table graphicRef96387 \">table 2</a>)) are typically used to maintain stroke volume through a combination of peripheral dilation and increased contractility (<a href=\"image.htm?imageKey=ANEST%2F96387\" class=\"graphic graphic_table graphicRef96387 \">table 2</a>). </p><p>Vasodilator therapy with <a href=\"topic.htm?path=nitroprusside-drug-information\" class=\"drug drug_general\">nitroprusside</a> may be helpful to decrease the severity of valvular regurgitation, thereby increasing forward cardiac output and diminishing pulmonary congestion. A very low dose of 5 to 10 <span class=\"nowrap\">mcg/minute</span> is initially administered and titrated to effect (<a href=\"image.htm?imageKey=ANEST%2F96387\" class=\"graphic graphic_table graphicRef96387 \">table 2</a>). Since high-dose nitroprusside administration for prolonged periods can lead to fetal cyanide toxicity, transition to <a href=\"topic.htm?path=nitroglycerin-glyceryl-trinitrate-drug-information\" class=\"drug drug_general\">nitroglycerin</a> or another vasodilating agent should occur as soon as possible. Immediately following delivery, either nitroglycerin or nitroprusside may cause profound uterine atony, resulting in postpartum hemorrhage. Although <a href=\"topic.htm?path=hydralazine-drug-information\" class=\"drug drug_general\">hydralazine</a> is an alternate vasodilating agent, titration in an acute situation is difficult due to its slow onset and long duration of action. (See <a href=\"topic.htm?path=acute-aortic-regurgitation-in-adults\" class=\"medical medical_review\">&quot;Acute aortic regurgitation in adults&quot;</a> and <a href=\"topic.htm?path=acute-mitral-regurgitation-in-adults\" class=\"medical medical_review\">&quot;Acute mitral regurgitation in adults&quot;</a>.) </p><p class=\"headingAnchor\" id=\"H136552748\"><span class=\"h1\">CYANOTIC CONGENITAL HEART DISEASE</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>A summary of key points for management of cyanotic congenital heart disease is provided in the table (<a href=\"image.htm?imageKey=ANEST%2F97438\" class=\"graphic graphic_table graphicRef97438 \">table 5</a>).</p><p class=\"headingAnchor\" id=\"H890691080\"><span class=\"h2\">Pathophysiology and hemodynamic management</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Women with cyanotic congenital heart disease are at high risk during labor and delivery. Patients with Eisenmenger&rsquo;s syndrome (ES; ie, patients with bidirectional intracardiac shunt, cyanosis, and pulmonary arterial hypertension) have a very high risk of pregnancy-related morbidity and mortality, and are always advised to avoid pregnancy. (See <a href=\"topic.htm?path=management-of-eisenmenger-syndrome#H6\" class=\"medical medical_review\">&quot;Management of Eisenmenger syndrome&quot;, section on 'Pregnancy'</a>.)</p><p>In patients with any shunt connecting the left and right sides of the circulation, maintaining blood flow through the pulmonary vasculature is the priority. Therefore, the pulmonary vascular resistance (PVR) and pulmonary artery pressures are kept as low as possible to minimize undesirable right-to-left shunting. For the same reason, systemic vascular resistance (SVR) (ie, systemic blood pressure [BP]) is kept relatively high. (See <a href=\"topic.htm?path=pregnancy-in-women-with-congenital-heart-disease-specific-lesions#H10\" class=\"medical medical_review\">&quot;Pregnancy in women with congenital heart disease: Specific lesions&quot;, section on 'Cyanotic congenital heart disease'</a> and <a href=\"topic.htm?path=pregnancy-in-women-with-congenital-heart-disease-general-principles#H344631071\" class=\"medical medical_review\">&quot;Pregnancy in women with congenital heart disease: General principles&quot;, section on 'Cyanosis'</a>.)</p><p>Key hemodynamic goals for patients with cyanotic congenital heart disease include: </p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Heart rate and rhythm</strong> &ndash; Sinus rhythm is preferable</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>SVR </strong>&ndash; Reductions in SVR cause undesirable right-to-left shunting and cyanosis. Maintain systolic BP &gt;100 mmHg, mean arterial BP &gt;70 mmHg, or both within 20 percent of baseline. Treat any suspected decrease in SVR immediately with an alpha adrenergic agonist such as <a href=\"topic.htm?path=phenylephrine-drug-information\" class=\"drug drug_general\">phenylephrine</a> administered as boluses (40 to 100 mcg), or an infusion (0.1 to 2 <span class=\"nowrap\">mcg/kg</span> per minute). <a href=\"topic.htm?path=norepinephrine-noradrenaline-drug-information\" class=\"drug drug_general\">Norepinephrine</a> may be administered if phenylephrine is ineffective (<a href=\"image.htm?imageKey=ANEST%2F96387\" class=\"graphic graphic_table graphicRef96387 \">table 2</a>).</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Preload</strong> &ndash; Allowing the intake of moderate amounts of clear fluids as per American Society of Anesthesiologists and American Congress of Obstetricians and Gynecologists guidelines is reasonable to prevent dehydration throughout labor [<a href=\"https://www.uptodate.com/contents/anesthesia-for-labor-and-delivery-in-high-risk-heart-disease-specific-lesions/abstract/1,2\" class=\"abstract_t\">1,2</a>]. If a laboring patient no longer desires to drink, maintenance of intravascular volume status and left-to-right shunt flow is facilitated by intravenous administration of maintenance fluid. This is initiated at 1 <span class=\"nowrap\">mL/kg</span> per hour and titrated according to clinical assessment of the patient&rsquo;s volume status and the hemodynamic response to any fluid boluses.</p><p/><p class=\"bulletIndent1\">Central venous catheterization is not recommended as a technique for routine monitoring of intravascular volume status. However, it is suggested if the patient requires vasoactive drug infusions or suffers severe peripartum hemorrhage.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Contractility</strong> &ndash; Avoid doses of drugs that might cause significant depression of myocardial contractility (eg, high doses of <a href=\"topic.htm?path=propofol-drug-information\" class=\"drug drug_general\">propofol</a> or volatile anesthetic agents).</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>PVR </strong>&ndash; Minimize PVR by avoiding further hypoxemia and administering supplemental oxygen. This may provide minimal benefit in select cyanotic patients; thus, avoiding oversedation and hypercarbia is critical. Also, treat pain and anxiety to minimize sympathetic stimulation.</p><p/><p class=\"bulletIndent1\">Routine use of a pulmonary artery catheter is contraindicated in ES patients, as there is a high potential for complications (eg, arrhythmia, thromboembolism, or pulmonary artery rupture) and outcomes are not improved [<a href=\"https://www.uptodate.com/contents/anesthesia-for-labor-and-delivery-in-high-risk-heart-disease-specific-lesions/abstract/5,6\" class=\"abstract_t\">5,6</a>].</p><p/><p class=\"headingAnchor\" id=\"H235805865\"><span class=\"h2\">Anesthetic techniques</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The following considerations apply to patients with cyanotic congenital heart disease: </p><p>An intra-arterial catheter is placed prior to administration of either a neuraxial technique or general anesthesia, since cyanotic patients can decompensate very quickly. Filters are placed on all intravenous lines as a precaution to prevent paradoxical venous air embolism if any temporary decrease in SVR occurs.</p><p class=\"headingAnchor\" id=\"H375330932\"><span class=\"h3\">Neuraxial analgesia for labor</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>We suggest a labor epidural, if feasible. The specific technique used for the test dose should be carefully considered. The analgesic block should be sufficiently dense to avoid any sympathetic stimulation from even mild labor pain. (See <a href=\"topic.htm?path=anesthesia-for-labor-and-delivery-in-high-risk-heart-disease-general-considerations#H77919293\" class=\"medical medical_review\">&quot;Anesthesia for labor and delivery in high-risk heart disease: General considerations&quot;, section on 'Neuraxial analgesia for labor'</a> and <a href=\"topic.htm?path=anesthesia-for-labor-and-delivery-in-high-risk-heart-disease-general-considerations#H1059864016\" class=\"medical medical_review\">&quot;Anesthesia for labor and delivery in high-risk heart disease: General considerations&quot;, section on 'Test dose administration'</a>.)</p><p class=\"headingAnchor\" id=\"H1005966029\"><span class=\"h3\">Neuraxial anesthesia for cesarean delivery</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>A very slowly titrated epidural anesthetic or a low-dose sequential combined spinal-epidural is reasonable after an intra-arterial catheter has been inserted for continuous monitoring of BP. (See <a href=\"topic.htm?path=anesthesia-for-labor-and-delivery-in-high-risk-heart-disease-general-considerations#H734055903\" class=\"medical medical_review\">&quot;Anesthesia for labor and delivery in high-risk heart disease: General considerations&quot;, section on 'Neuraxial anesthesia for cesarean delivery'</a>.)</p><p>Avoid spinal anesthesia, because the rapid onset of a sympathectomy and consequent decrease in SVR results in right-to-left shunting and worsening cyanosis.</p><p>Treat hypotension immediately by infusion of <a href=\"topic.htm?path=phenylephrine-drug-information\" class=\"drug drug_general\">phenylephrine</a>, which should be prepared and immediately available. <a href=\"topic.htm?path=norepinephrine-noradrenaline-drug-information\" class=\"drug drug_general\">Norepinephrine</a> should also be available in the event that phenylephrine is ineffective (<a href=\"image.htm?imageKey=ANEST%2F96387\" class=\"graphic graphic_table graphicRef96387 \">table 2</a>). (See <a href=\"topic.htm?path=anesthesia-for-labor-and-delivery-in-high-risk-heart-disease-general-considerations#H734055903\" class=\"medical medical_review\">&quot;Anesthesia for labor and delivery in high-risk heart disease: General considerations&quot;, section on 'Neuraxial anesthesia for cesarean delivery'</a>.)</p><p>There is a high potential for hypotension immediately after birth, and during initiation of post-delivery oxytocin therapy [<a href=\"https://www.uptodate.com/contents/anesthesia-for-labor-and-delivery-in-high-risk-heart-disease-specific-lesions/abstract/7\" class=\"abstract_t\">7</a>]. (See <a href=\"topic.htm?path=anesthesia-for-cesarean-delivery#H3570978273\" class=\"medical medical_review\">&quot;Anesthesia for cesarean delivery&quot;, section on 'Prevention of postpartum hemorrhage'</a>.) Hypotension resulting from oxytocin should be treated with <a href=\"topic.htm?path=phenylephrine-drug-information\" class=\"drug drug_general\">phenylephrine</a> or <a href=\"topic.htm?path=norepinephrine-noradrenaline-drug-information\" class=\"drug drug_general\">norepinephrine</a> (<a href=\"image.htm?imageKey=ANEST%2F96387\" class=\"graphic graphic_table graphicRef96387 \">table 2</a>). (See <a href=\"topic.htm?path=anesthesia-for-labor-and-delivery-in-high-risk-heart-disease-general-considerations#H734055903\" class=\"medical medical_review\">&quot;Anesthesia for labor and delivery in high-risk heart disease: General considerations&quot;, section on 'Neuraxial anesthesia for cesarean delivery'</a>.) </p><p class=\"headingAnchor\" id=\"H1005966035\"><span class=\"h3\">General anesthesia for cesarean delivery</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>If general anesthesia is needed for cesarean delivery, an intra-arterial catheter is inserted prior to induction.</p><p>Induction with <a href=\"topic.htm?path=etomidate-drug-information\" class=\"drug drug_general\">etomidate</a> 0.2 to 0.3 <span class=\"nowrap\">mg/kg</span> or <a href=\"topic.htm?path=ketamine-drug-information\" class=\"drug drug_general\">ketamine</a> 1 to 1.5 <span class=\"nowrap\">mg/kg,</span> often combined with <a href=\"topic.htm?path=fentanyl-drug-information\" class=\"drug drug_general\">fentanyl</a> 1 to 2 <span class=\"nowrap\">mcg/kg</span> or <a href=\"topic.htm?path=remifentanil-drug-information\" class=\"drug drug_general\">remifentanil</a> 1 <span class=\"nowrap\">mcg/kg</span> [<a href=\"https://www.uptodate.com/contents/anesthesia-for-labor-and-delivery-in-high-risk-heart-disease-specific-lesions/abstract/3,4\" class=\"abstract_t\">3,4</a>] is suggested to avoid a sudden decrease in SVR and possible hemodynamic collapse. Avoid agents and techniques that decrease SVR (eg, high doses of <a href=\"topic.htm?path=propofol-drug-information\" class=\"drug drug_general\">propofol</a>).</p><p>Avoid sympathetic stimulation during intubation and surgical incision by providing adequate doses of induction and maintenance agents during critical periods. Avoid <a href=\"topic.htm?path=nitrous-oxide-drug-information\" class=\"drug drug_general\">nitrous oxide</a> because it can increase PVR.</p><p>During controlled ventilation, minimize PVR by avoiding hypercapnia and administering 100 percent O<sub>2 </sub>to maintain the highest possible PaO<sub>2</sub>. Moderate hyperventilation to maintain PaCO<sub>2</sub> at approximately 28 to 30 mmHg is reasonable. Optimize ventilation to achieve low peak and mean airway pressures. Avoid positive end-expiratory pressure and overinflation of the lungs, since this may also increase PVR. Treat bronchospasm promptly to avoid lung hyperinflation.</p><p>During general anesthesia, transesophageal echocardiography provides rapid qualitative assessment of ventricular preload and function, as well as estimation of shunt severity. Although this is not a routinely recommended monitor, it is an invaluable diagnostic tool in unstable patients.</p><p>Tailor postoperative pain management to avoid oversedation (and consequent hypoxemia and hypercarbia) in spontaneously breathing patients. (See <a href=\"topic.htm?path=anesthesia-for-labor-and-delivery-in-high-risk-heart-disease-general-considerations#H734055828\" class=\"medical medical_review\">&quot;Anesthesia for labor and delivery in high-risk heart disease: General considerations&quot;, section on 'General anesthesia technique for cesarean delivery'</a>.)</p><p class=\"headingAnchor\" id=\"H235806873\"><span class=\"h1\">ISCHEMIC HEART DISEASE</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>A summary of key points for management of ischemic heart disease is provided in the table (<a href=\"image.htm?imageKey=ANEST%2F97439\" class=\"graphic graphic_table graphicRef97439 \">table 6</a>).</p><p class=\"headingAnchor\" id=\"H1159737271\"><span class=\"h2\">Pathophysiology and hemodynamic management</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In patients with symptomatic or severe ischemic heart disease, optimizing myocardial oxygen supply and minimizing myocardial oxygen demand are of primary importance (<a href=\"image.htm?imageKey=ANEST%2F91907\" class=\"graphic graphic_table graphicRef91907 \">table 7</a>).</p><p>Myocardial oxygen supply is determined by the oxygen (O<sub>2</sub>)<sub> </sub>content of arterial blood and by the blood flow in the coronary arteries. High arterial PaO<sub>2</sub> and adequate hemoglobin level ensure maximal O<sub>2 </sub>content. Adequate diastolic blood pressure (BP) (eg, &gt;70 mmHg) maintains coronary perfusion pressure, estimated as the diastolic BP minus the &ldquo;back-pressure&rdquo; approximated by the left ventricular end-diastolic pressure (LVEDP). A slow heart rate (HR; eg, &lt;80 <span class=\"nowrap\">beats/min)</span> is important since 70 to 80 percent of coronary blood flow occurs during diastole and the total time per minute spent in diastole is a function of HR (<a href=\"image.htm?imageKey=ANEST%2F94174\" class=\"graphic graphic_figure graphicRef94174 \">figure 1</a>).</p><p>Myocardial oxygen demand is determined by HR, as well as by contractility and wall stress. Myocardial O<sub>2</sub> demand more than doubles with a twofold increase in HR [<a href=\"https://www.uptodate.com/contents/anesthesia-for-labor-and-delivery-in-high-risk-heart-disease-specific-lesions/abstract/8\" class=\"abstract_t\">8</a>]. Also, excessive increases in chamber size or left ventricular systolic pressure will elevate O<sub>2</sub> demand by increasing systolic wall stress. </p><p>Note that tachycardia, as well as increased LVEDP, are particularly undesirable because these factors both decrease myocardial O<sub>2</sub> supply and increase myocardial O<sub>2 </sub>demand. (See <a href=\"topic.htm?path=management-of-cardiac-risk-for-noncardiac-surgery\" class=\"medical medical_review\">&quot;Management of cardiac risk for noncardiac surgery&quot;</a> and <a href=\"topic.htm?path=anesthesia-for-noncardiac-surgery-in-patients-with-ischemic-heart-disease\" class=\"medical medical_review\">&quot;Anesthesia for noncardiac surgery in patients with ischemic heart disease&quot;</a>.)</p><p>Key hemodynamic goals for patients with ischemic heart disease include: </p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Heart rate and rhythm</strong> &ndash; Avoid tachycardia. Use a 5-lead electrocardiogram to continuously monitor HR and for evidence of myocardial ischemia. Computerized ST-segment trending is superior to visual clinical interpretation in the identification of ST-segment changes [<a href=\"https://www.uptodate.com/contents/anesthesia-for-labor-and-delivery-in-high-risk-heart-disease-specific-lesions/abstract/9-11\" class=\"abstract_t\">9-11</a>] and multiple-lead monitoring is more sensitive than single-lead monitoring [<a href=\"https://www.uptodate.com/contents/anesthesia-for-labor-and-delivery-in-high-risk-heart-disease-specific-lesions/abstract/12\" class=\"abstract_t\">12</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Systemic vascular resistance (SVR)</strong> &ndash; Maintain systolic BP &gt;100 mmHg, mean arterial BP &gt;70 mmHg, or both within 20 percent of baseline. Treat hypotension due to decreased SVR with <a href=\"topic.htm?path=phenylephrine-drug-information\" class=\"drug drug_general\">phenylephrine</a> administered as boluses (40 to 100 mcg) or an infusion (0.1 to 2 <span class=\"nowrap\">mcg/kg</span> per minute). <a href=\"topic.htm?path=norepinephrine-noradrenaline-drug-information\" class=\"drug drug_general\">Norepinephrine</a> may be administered if phenylephrine is ineffective (<a href=\"image.htm?imageKey=ANEST%2F96387\" class=\"graphic graphic_table graphicRef96387 \">table 2</a>).</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Preload</strong> &ndash; Maintain adequate intravascular volume (preload). Allowing the intake of moderate amounts of clear fluids as per American Society of Anesthesiologists and American Congress of Obstetricians and Gynecologists guidelines is reasonable to prevent dehydration throughout labor [<a href=\"https://www.uptodate.com/contents/anesthesia-for-labor-and-delivery-in-high-risk-heart-disease-specific-lesions/abstract/1,2\" class=\"abstract_t\">1,2</a>]. </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Contractility</strong> &ndash; Myocardial contractility may be maintained or slightly decreased (eg, with beta blockers or a volatile inhalation agent if a general anesthetic is required). This is appropriate in patients with ischemic heart disease and preserved LV systolic function. However, patients with heart failure and a severely reduced LV ejection fraction should not receive high doses of beta blockers or volatile anesthetics.</p><p/><p class=\"headingAnchor\" id=\"H235806915\"><span class=\"h2\">Anesthetic techniques</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The following considerations apply to patients with ischemic heart disease. </p><p class=\"headingAnchor\" id=\"H375331076\"><span class=\"h3\">Neuraxial analgesia for labor</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>We suggest a labor epidural, if feasible. The specific technique used for the test dose should be carefully considered. The analgesic block should be sufficiently dense to avoid any sympathetic stimulation from even mild labor pain. (See <a href=\"topic.htm?path=anesthesia-for-labor-and-delivery-in-high-risk-heart-disease-general-considerations#H77919293\" class=\"medical medical_review\">&quot;Anesthesia for labor and delivery in high-risk heart disease: General considerations&quot;, section on 'Neuraxial analgesia for labor'</a> and <a href=\"topic.htm?path=anesthesia-for-labor-and-delivery-in-high-risk-heart-disease-general-considerations#H1059864016\" class=\"medical medical_review\">&quot;Anesthesia for labor and delivery in high-risk heart disease: General considerations&quot;, section on 'Test dose administration'</a>.)</p><p class=\"headingAnchor\" id=\"H19441235\"><span class=\"h3\">Neuraxial anesthesia for cesarean delivery</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Generally, patients with ischemic heart disease tolerate a spinal or epidural anesthetic if hypotension is avoided or treated promptly. Depending on the severity of ischemic disease, an intra-arterial catheter may be inserted for continuous BP monitoring prior to a neuraxial intervention so that hypotension can be immediately detected and treated. (See <a href=\"topic.htm?path=anesthesia-for-labor-and-delivery-in-high-risk-heart-disease-general-considerations#H734055903\" class=\"medical medical_review\">&quot;Anesthesia for labor and delivery in high-risk heart disease: General considerations&quot;, section on 'Neuraxial anesthesia for cesarean delivery'</a>.)</p><p class=\"headingAnchor\" id=\"H58268596\"><span class=\"h3\">General anesthesia for cesarean delivery</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>If general anesthesia is needed for urgent cesarean delivery, the goal is to produce unconsciousness, with attenuation of the hemodynamic responses to noxious stimuli (eg, tachycardia) but without inducing hypotension. (See <a href=\"topic.htm?path=anesthesia-for-labor-and-delivery-in-high-risk-heart-disease-general-considerations#H734055828\" class=\"medical medical_review\">&quot;Anesthesia for labor and delivery in high-risk heart disease: General considerations&quot;, section on 'General anesthesia technique for cesarean delivery'</a> and <a href=\"topic.htm?path=anesthesia-for-noncardiac-surgery-in-patients-with-ischemic-heart-disease#H2200606372\" class=\"medical medical_review\">&quot;Anesthesia for noncardiac surgery in patients with ischemic heart disease&quot;, section on 'Induction'</a>.) </p><p>Use of beta blockers to avoid tachycardia during laryngoscopy and subsequent surgical stimulation is reasonable. Avoid induction agents that cause tachycardia (eg, <a href=\"topic.htm?path=ketamine-drug-information\" class=\"drug drug_general\">ketamine</a>) or markedly decrease SVR (eg, high doses of <a href=\"topic.htm?path=propofol-drug-information\" class=\"drug drug_general\">propofol</a>). Some clinicians use <a href=\"topic.htm?path=remifentanil-drug-information\" class=\"drug drug_general\">remifentanil</a>, an &ldquo;ultra-short&rdquo;-acting opioid, as a supplemental agent during and after induction to provide hemodynamic stability (eg, avoiding tachycardia) without causing prolonged neonatal depression [<a href=\"https://www.uptodate.com/contents/anesthesia-for-labor-and-delivery-in-high-risk-heart-disease-specific-lesions/abstract/3,4\" class=\"abstract_t\">3,4</a>].</p><p>Treat any episode of tachycardia promptly by deepening general anesthesia or administering beta blockers (eg, <a href=\"topic.htm?path=esmolol-drug-information\" class=\"drug drug_general\">esmolol</a>, <a href=\"topic.htm?path=labetalol-drug-information\" class=\"drug drug_general\">labetalol</a>, or <a href=\"topic.htm?path=metoprolol-drug-information\" class=\"drug drug_general\">metoprolol</a>) to control heart rate. Treat hypotension by infusion of <a href=\"topic.htm?path=phenylephrine-drug-information\" class=\"drug drug_general\">phenylephrine</a>. Also, administer fluid to optimize intravascular volume, as evidenced by an acceptable BP.</p><p>For maintenance of general anesthesia, a volatile anesthetic is used. Volatile anesthetics may have cardioprotective effects, including mitigating reperfusion injury and triggering the myocardial preconditioning cascade. Both <a href=\"topic.htm?path=sevoflurane-drug-information\" class=\"drug drug_general\">sevoflurane</a> and <a href=\"topic.htm?path=isoflurane-drug-information\" class=\"drug drug_general\">isoflurane</a> are reasonable choices. <a href=\"topic.htm?path=desflurane-drug-information\" class=\"drug drug_general\">Desflurane</a> is less desirable, because it may cause tachycardia. (See <a href=\"topic.htm?path=anesthesia-for-noncardiac-surgery-in-patients-with-ischemic-heart-disease#H2200606364\" class=\"medical medical_review\">&quot;Anesthesia for noncardiac surgery in patients with ischemic heart disease&quot;, section on 'Maintenance'</a>.)</p><p>During emergence and tracheal extubation, tachycardia and hypertension may lead to myocardial ischemia. Prevent or control these hemodynamic changes by optimizing perioperative analgesia, as well as administering intravenous beta blockers <span class=\"nowrap\">and/or</span> vasodilating agents. Advanced therapy and intervention may be needed if symptoms or ischemia persist despite initial therapy. (See <a href=\"topic.htm?path=anesthesia-for-noncardiac-surgery-in-patients-with-ischemic-heart-disease#H2200607745\" class=\"medical medical_review\">&quot;Anesthesia for noncardiac surgery in patients with ischemic heart disease&quot;, section on 'Emergence'</a>.)</p><p class=\"headingAnchor\" id=\"H252769369\"><span class=\"h1\">DILATED CARDIOMYOPATHIES AND CARDIOMYOPATHY ASSOCIATED WITH PREECLAMPSIA</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>A summary of key points for management of patients with cardiomyopathies is provided in the table (<a href=\"image.htm?imageKey=ANEST%2F97440\" class=\"graphic graphic_table graphicRef97440 \">table 8</a>).</p><p class=\"headingAnchor\" id=\"H1542094901\"><span class=\"h2\">Pathophysiology and hemodynamic management</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Patients with dilated cardiomyopathy, including peripartum cardiomyopathy, are at risk for congestive heart failure and arrhythmias. The increased metabolic demand during labor and delivery must be met by an increase in oxygen delivery. This increase is typically achieved by increasing cardiac output with alterations in heart rate (HR), systemic vascular resistance (SVR), preload, and myocardial contractility. (See <a href=\"topic.htm?path=acquired-heart-disease-and-pregnancy#H14\" class=\"medical medical_review\">&quot;Acquired heart disease and pregnancy&quot;, section on 'Cardiomyopathy'</a> and <a href=\"topic.htm?path=peripartum-cardiomyopathy-etiology-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">&quot;Peripartum cardiomyopathy: Etiology, clinical manifestations, and diagnosis&quot;</a> and <a href=\"topic.htm?path=management-of-heart-failure-during-pregnancy\" class=\"medical medical_review\">&quot;Management of heart failure during pregnancy&quot;</a>.)</p><p>Key hemodynamic goals for patients with these cardiomyopathies include: </p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Heart rate and rhythm</strong> &ndash; Maintain a normal to increased HR (ie, 80 to 100 <span class=\"nowrap\">beats/minute)</span> in order to maintain cardiac output despite a low stroke volume.</p><p/><p class=\"bulletIndent1\">Patients with dilated cardiomyopathy often have a biventricular pacemaker <span class=\"nowrap\">and/or</span> implantable cardioverter-defibrillator device. The anti-tachyarrhythmic function of the device should remain active during labor. However, if cesarean delivery is needed, the device should be managed in a way to avoid electromagnetic interference (EMI) caused by use of electrocautery, which could either interfere with pacing or cause a defibrillation shock to be delivered inappropriately. Early communication with the cardiac implantable electronic devices (CIED) care team is necessary to understand important information about the type of device, adequacy of function, and specific perioperative recommendations for reprogramming with a programming machine or magnet application, and clinical implications of the expected response (<a href=\"image.htm?imageKey=ANEST%2F116023\" class=\"graphic graphic_algorithm graphicRef116023 \">algorithm 1</a> and <a href=\"image.htm?imageKey=ANEST%2F116028\" class=\"graphic graphic_algorithm graphicRef116028 \">algorithm 2</a>). Transcutaneous <span class=\"nowrap\">pacing/defibrillator</span> pads are placed on the patient before or shortly after the anti-tachyarrhythmia functions of an implantable cardioverter-defibrillator (ICD) is electively disabled <span class=\"nowrap\">and/or</span> asynchronous pacing has been enabled so that malignant arrhythmias can be immediately treated (<a href=\"image.htm?imageKey=ANEST%2F109150\" class=\"graphic graphic_figure graphicRef109150 \">figure 2</a>). Also, an external defibrillator with pacing capability should be immediately available. Other aspects of perioperative management of CIEDs are discussed elsewhere [<a href=\"https://www.uptodate.com/contents/anesthesia-for-labor-and-delivery-in-high-risk-heart-disease-specific-lesions/abstract/13,14\" class=\"abstract_t\">13,14</a>]. (See <a href=\"topic.htm?path=perioperative-management-of-patients-with-a-pacemaker-or-implantable-cardioverter-defibrillator\" class=\"medical medical_review\">&quot;Perioperative management of patients with a pacemaker or implantable cardioverter-defibrillator&quot;</a>.)</p><p/><p class=\"bulletIndent1\">For emergency cesarean delivery when there is inadequate time for preoperative reprogramming, a magnet is applied prior to use of electrocautery or any other device that may cause EMI. It is essential to place transcutaneous <span class=\"nowrap\">pacing/defibrillator</span> pads and to ensure continuous ECG and pulse oximeter plethysmography monitoring throughout surgery. Other aspects of emergency management with a magnet are discussed separately. (See <a href=\"topic.htm?path=perioperative-management-of-patients-with-a-pacemaker-or-implantable-cardioverter-defibrillator#H2753205\" class=\"medical medical_review\">&quot;Perioperative management of patients with a pacemaker or implantable cardioverter-defibrillator&quot;, section on 'Emergency surgery'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>SVR </strong>&ndash; Minimize sympathetic stimulation, which can cause significant increases in SVR and result in reduced cardiac output. On the other hand, sudden decreases in SVR should also be avoided, as the resulting hypotension may cause myocardial ischemia. </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Preload</strong> &ndash; Avoid dehydration or sudden decreases in preload, since adequate preload is necessary for maintenance of adequate cardiac output and perfusion to the placenta and vital organs.</p><p/><p class=\"bulletIndent1\">Also, avoid excessive fluid administration because these patients are at risk for volume overload and congestive heart failure. </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Contractility</strong> &ndash; Avoid myocardial depressants (eg, high doses of <a href=\"topic.htm?path=propofol-drug-information\" class=\"drug drug_general\">propofol</a> or volatile anesthetic agents). Patients with cardiomyopathy and markedly reduced left ventricular (LV) systolic function may be particularly sensitive to the effects of these agents.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Pulmonary vascular resistance (PVR) </strong>&ndash; Minimize PVR by avoiding hypoxemia and hypercarbia. Administer supplemental oxygen and avoid oversedation. Minimize sympathetic stimulation by effective treatment of pain and anxiety. </p><p/><p class=\"headingAnchor\" id=\"H252769442\"><span class=\"h2\">Anesthetic techniques</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The following considerations apply to patients with symptomatic dilated cardiomyopathy. (See <a href=\"topic.htm?path=anesthesia-for-noncardiac-surgery-in-patients-with-heart-failure\" class=\"medical medical_review\">&quot;Anesthesia for noncardiac surgery in patients with heart failure&quot;</a>.)</p><p>An intra-arterial catheter is inserted for continuous blood pressure (BP) monitoring prior to initiating any analgesic or anesthetic technique, in order to immediately detect and treat hypotension. Furthermore, an arterial catheter facilitates management of vasoactive infusions. In patients with severe cardiomyopathy and very poor left <span class=\"nowrap\">and/or</span> right ventricular function, an arterial line is placed early in labor, prior to epidural placement and prior to the onset of painful contractions.</p><p>Insertion of a central venous catheter is sometimes indicated (eg, when administration of vasoactive infusions is necessary). Use of a pulmonary artery catheter is rarely indicated.</p><p class=\"headingAnchor\" id=\"H375331188\"><span class=\"h3\">Neuraxial analgesia for labor</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>We suggest a labor epidural, if feasible. However, regional anesthesia is contraindicated in anticoagulated patients. Guidelines for placement of neuraxial anesthesia in patients on anticoagulant medications should be followed. (See <a href=\"topic.htm?path=neuraxial-anesthesia-analgesia-techniques-in-the-patient-receiving-anticoagulant-or-antiplatelet-medication\" class=\"medical medical_review\">&quot;Neuraxial anesthesia/analgesia techniques in the patient receiving anticoagulant or antiplatelet medication&quot;</a>.) The specific technique used for the test dose should be carefully considered. The analgesic block should be sufficiently dense to avoid any sympathetic stimulation from even mild labor pain. (See <a href=\"topic.htm?path=anesthesia-for-labor-and-delivery-in-high-risk-heart-disease-general-considerations#H77919293\" class=\"medical medical_review\">&quot;Anesthesia for labor and delivery in high-risk heart disease: General considerations&quot;, section on 'Neuraxial analgesia for labor'</a> and <a href=\"topic.htm?path=anesthesia-for-labor-and-delivery-in-high-risk-heart-disease-general-considerations#H1059864016\" class=\"medical medical_review\">&quot;Anesthesia for labor and delivery in high-risk heart disease: General considerations&quot;, section on 'Test dose administration'</a>.) </p><p class=\"headingAnchor\" id=\"H58268590\"><span class=\"h3\">Neuraxial anesthesia for cesarean delivery</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>A very slowly titrated epidural anesthetic or a low-dose sequential combined spinal-epidural (CSE) has the advantage of decreasing preload and afterload. (See <a href=\"topic.htm?path=anesthesia-for-labor-and-delivery-in-high-risk-heart-disease-general-considerations#H734055903\" class=\"medical medical_review\">&quot;Anesthesia for labor and delivery in high-risk heart disease: General considerations&quot;, section on 'Neuraxial anesthesia for cesarean delivery'</a>.) Theoretically, this may help to accommodate the sudden increase in intravascular volume that occurs due to autotransfusion and aorto-caval decompression after delivery.</p><p>Spinal anesthesia is generally avoided because of the possibility of rapid sympathectomy, which can cause life-threatening hypotension. If spinal anesthesia is chosen, then intra-arterial BP monitoring should be employed and a <a href=\"topic.htm?path=phenylephrine-drug-information\" class=\"drug drug_general\">phenylephrine</a> infusion at 0.5 <span class=\"nowrap\">mcg/kg/min</span> is initiated at the time of spinal placement and subsequently titrated to keep BP as close to baseline as possible.</p><p>Likewise, if an epidural or sequential CSE technique is utilized, titration of the epidural level can be accompanied by titration of an infusion of <a href=\"topic.htm?path=phenylephrine-drug-information\" class=\"drug drug_general\">phenylephrine</a> or <a href=\"topic.htm?path=norepinephrine-noradrenaline-drug-information\" class=\"drug drug_general\">norepinephrine</a> to maintain BP. These agents should be prepared and readily available (<a href=\"image.htm?imageKey=ANEST%2F96387\" class=\"graphic graphic_table graphicRef96387 \">table 2</a>).</p><p>There is a potential for hypotension immediately after birth and during initiation of post-delivery oxytocin therapy [<a href=\"https://www.uptodate.com/contents/anesthesia-for-labor-and-delivery-in-high-risk-heart-disease-specific-lesions/abstract/7\" class=\"abstract_t\">7</a>]. Hypotension resulting from an oxytocin infusion should be treated with <a href=\"topic.htm?path=phenylephrine-drug-information\" class=\"drug drug_general\">phenylephrine</a> or <a href=\"topic.htm?path=norepinephrine-noradrenaline-drug-information\" class=\"drug drug_general\">norepinephrine</a> (<a href=\"image.htm?imageKey=ANEST%2F96387\" class=\"graphic graphic_table graphicRef96387 \">table 2</a>). (See <a href=\"topic.htm?path=anesthesia-for-cesarean-delivery#H3570978273\" class=\"medical medical_review\">&quot;Anesthesia for cesarean delivery&quot;, section on 'Prevention of postpartum hemorrhage'</a>.) </p><p class=\"headingAnchor\" id=\"H58268820\"><span class=\"h3\">General anesthesia for cesarean delivery</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>If general anesthesia is needed for cesarean delivery, we prefer induction with <a href=\"topic.htm?path=etomidate-drug-information\" class=\"drug drug_general\">etomidate</a> 0.2 to 0.3 <span class=\"nowrap\">mg/kg</span> or <a href=\"topic.htm?path=ketamine-drug-information\" class=\"drug drug_general\">ketamine</a> 1 to 1.5 <span class=\"nowrap\">mg/kg,</span> supplemented with <a href=\"topic.htm?path=fentanyl-drug-information\" class=\"drug drug_general\">fentanyl</a> 1 to 2 <span class=\"nowrap\">mcg/kg,</span> to avoid a sudden decrease in SVR and subsequent hemodynamic collapse. (See <a href=\"topic.htm?path=anesthesia-for-labor-and-delivery-in-high-risk-heart-disease-general-considerations#H734055828\" class=\"medical medical_review\">&quot;Anesthesia for labor and delivery in high-risk heart disease: General considerations&quot;, section on 'General anesthesia technique for cesarean delivery'</a>.) A bolus dose of <a href=\"topic.htm?path=propofol-drug-information\" class=\"drug drug_general\">propofol</a> can cause a deleterious marked reduction in SVR and some degree of myocardial depression. However, if propofol is selected for induction, an arterial line should be in place and the drug should be administered in divided small doses, titrated to effect, with anticipated decreases in SVR prophylactically or immediately treated with <a href=\"topic.htm?path=phenylephrine-drug-information\" class=\"drug drug_general\">phenylephrine</a> boluses. &#160;</p><p>In patients with severe LV systolic dysfunction and low cardiac output syndrome, it may be necessary to administer inotropic agents such as <a href=\"topic.htm?path=milrinone-drug-information\" class=\"drug drug_general\">milrinone</a> or <a href=\"topic.htm?path=dobutamine-drug-information\" class=\"drug drug_general\">dobutamine</a> (<a href=\"image.htm?imageKey=ANEST%2F96387\" class=\"graphic graphic_table graphicRef96387 \">table 2</a>). However, during general anesthesia, milrinone infusion may result in excessive hypotension, necessitating administration of additional <span class=\"nowrap\">inotropic/vasopressor</span> agents to maintain acceptable blood pressure, such as <a href=\"topic.htm?path=norepinephrine-noradrenaline-drug-information\" class=\"drug drug_general\">norepinephrine</a>, <a href=\"topic.htm?path=epinephrine-adrenaline-drug-information\" class=\"drug drug_general\">epinephrine</a>, or <a href=\"topic.htm?path=dopamine-drug-information\" class=\"drug drug_general\">dopamine</a> (<a href=\"image.htm?imageKey=ANEST%2F96387\" class=\"graphic graphic_table graphicRef96387 \">table 2</a>). </p><p>During general anesthesia, transesophageal echocardiography may be useful to guide fluid management and vasoactive drug therapy.</p><p class=\"headingAnchor\" id=\"H58268891\"><span class=\"h2\">Cardiomyopathy associated with preeclampsia</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Patients with preeclampsia and associated heart failure are a particularly challenging subgroup of cardiomyopathy patients. Prompt delivery is usually indicated, either vaginally or by cesarean, as this is the only cure for preeclampsia. Thus, emergency cesarean delivery is common in this subgroup.</p><p>These patients are exquisitely sensitive to endogenous and exogenous catecholamines. The sympathetic stimulation that accompanies tracheal intubation <span class=\"nowrap\">and/or</span> surgical incision is poorly tolerated due to the excessive increase in LV afterload, and may lead to acute decompensated heart failure or severe hypertension and stroke. The goal is to keep the systolic BP &lt;160 mmHg.</p><p>Conversely, these patients may develop significant hypotension if SVR decreases during induction of either regional or general anesthesia, because they are unable to compensate by increasing their cardiac output. Patients with preeclampsia have intravascular fluid depletion, which further complicates hemodynamic management. They may also have a degree of diastolic dysfunction and cannot readily increase their stroke volume [<a href=\"https://www.uptodate.com/contents/anesthesia-for-labor-and-delivery-in-high-risk-heart-disease-specific-lesions/abstract/15\" class=\"abstract_t\">15</a>]. </p><p class=\"headingAnchor\" id=\"H58268809\"><span class=\"h3\">Neuraxial anesthesia for labor</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>As in other cardiomyopathies, we suggest a labor epidural, if feasible. The specific technique used for the test dose should be carefully considered. (See <a href=\"topic.htm?path=anesthesia-for-labor-and-delivery-in-high-risk-heart-disease-general-considerations#H77919293\" class=\"medical medical_review\">&quot;Anesthesia for labor and delivery in high-risk heart disease: General considerations&quot;, section on 'Neuraxial analgesia for labor'</a> and <a href=\"topic.htm?path=anesthesia-for-labor-and-delivery-in-high-risk-heart-disease-general-considerations#H1059864016\" class=\"medical medical_review\">&quot;Anesthesia for labor and delivery in high-risk heart disease: General considerations&quot;, section on 'Test dose administration'</a>.)</p><p>An intra-arterial catheter to continuously monitor BP should be inserted as early as possible in labor, prior to epidural placement and prior to significant catecholamine release from pain. The analgesic block should be sufficiently dense to avoid any sympathetic stimulation from even mild labor pain. A <a href=\"topic.htm?path=phenylephrine-drug-information\" class=\"drug drug_general\">phenylephrine</a> infusion should be immediately available to treat hypotension.</p><p class=\"headingAnchor\" id=\"H375331315\"><span class=\"h3\">Neuraxial anesthesia for cesarean delivery</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The anesthetic considerations noted above for neuraxial anesthesia in patients with dilated cardiomyopathy are applicable. (See <a href=\"#H252769369\" class=\"local\">'Dilated cardiomyopathies and cardiomyopathy associated with preeclampsia'</a> above.) However, preeclamptic patients often have significant pulmonary edema limiting their ability to lie flat during surgery. If this is the case, and the team is unable to find a position that allows the obstetricians to perform the surgery while the patient is able to breathe, then general anesthesia is indicated.</p><p class=\"headingAnchor\" id=\"H66801414\"><span class=\"h3\">General anesthesia for cesarean delivery</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Placement of an intra-arterial catheter should be accomplished prior to induction of general anesthesia. It is prudent to forego a rapid sequence induction in these patients and focus entirely on hemodynamic control. The target is maintenance of a systolic blood pressure &lt;160 mmHg. (See <a href=\"topic.htm?path=management-of-hypertension-in-pregnant-and-postpartum-women#H11\" class=\"medical medical_review\">&quot;Management of hypertension in pregnant and postpartum women&quot;, section on 'Target blood pressure'</a>.)</p><p>A reasonable approach is a controlled induction of general anesthesia with an intravenous induction agent (eg, <a href=\"topic.htm?path=etomidate-drug-information\" class=\"drug drug_general\">etomidate</a> 0.2 <span class=\"nowrap\">mg/kg</span> or <a href=\"topic.htm?path=propofol-drug-information\" class=\"drug drug_general\">propofol</a> 0.5 to 1 <span class=\"nowrap\">mg/kg),</span> titrated to clinical effect, and supplemented with <a href=\"topic.htm?path=lidocaine-drug-information\" class=\"drug drug_general\">lidocaine</a> 50 to 100 mg [<a href=\"https://www.uptodate.com/contents/anesthesia-for-labor-and-delivery-in-high-risk-heart-disease-specific-lesions/abstract/16\" class=\"abstract_t\">16</a>] and a relatively high dose of opioid (eg, 5 to 8 <span class=\"nowrap\">mcg/kg</span> of <a href=\"topic.htm?path=fentanyl-drug-information\" class=\"drug drug_general\">fentanyl</a>) to mitigate the catecholamine response to laryngoscopy. <a href=\"topic.htm?path=ketamine-drug-information\" class=\"drug drug_general\">Ketamine</a> is contraindicated in preeclampsia because of its sympathomimetic effects, which may exacerbate hypertension and systemic vasoconstriction. (See <a href=\"topic.htm?path=anesthesia-for-labor-and-delivery-in-high-risk-heart-disease-general-considerations#H734055828\" class=\"medical medical_review\">&quot;Anesthesia for labor and delivery in high-risk heart disease: General considerations&quot;, section on 'General anesthesia technique for cesarean delivery'</a>.) </p><p>Any induction technique utilizing high-dose opioids requires notification of the neonatology team so that preparations can be made for possible respiratory support of the newborn.</p><p>After delivery, the mother is transferred to an intensive care unit, because of the continuing risk for arrhythmias, worsening heart failure, and sudden death.</p><p class=\"headingAnchor\" id=\"H327450595\"><span class=\"h1\">HYPERTROPHIC CARDIOMYOPATHY (HCM)</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>A summary of key points for management of hypertrophic cardiomyopathy (HCM) is provided in the table (<a href=\"image.htm?imageKey=ANEST%2F97442\" class=\"graphic graphic_table graphicRef97442 \">table 9</a>).</p><p class=\"headingAnchor\" id=\"H498240021\"><span class=\"h2\">Pathophysiology and hemodynamic management</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Patients with HCM have inappropriate hypertrophy of the left ventricular (LV) myocardium. Although patients with this genetically-associated cardiomyopathy may present with a heterogeneous spectrum of clinical signs and symptoms, the most common syndrome involves the obstructive variant of this disorder which is associated with variable degrees of LV outflow tract (LVOT) obstruction and mitral regurgitation (MR) [<a href=\"https://www.uptodate.com/contents/anesthesia-for-labor-and-delivery-in-high-risk-heart-disease-specific-lesions/abstract/17-19\" class=\"abstract_t\">17-19</a>]. (See <a href=\"topic.htm?path=hypertrophic-cardiomyopathy-clinical-manifestations-diagnosis-and-evaluation\" class=\"medical medical_review\">&quot;Hypertrophic cardiomyopathy: Clinical manifestations, diagnosis, and evaluation&quot;</a>.)</p><p>LVOT obstruction and MR are dynamic processes in patients with HCM. Obstruction is observed on transthoracic echocardiography (TTE) or transesophageal echocardiography (TEE) when the LVOT is narrowed by marked LV septal hypertrophy <span class=\"nowrap\">and/or</span> abnormal length and positioning of the mitral valve leaflets with resultant systolic mitral leaflet-septal contact (<a href=\"image.htm?imageKey=ANEST%2F102345\" class=\"graphic graphic_diagnosticimage graphicRef102345 \">image 1</a> and <a href=\"image.htm?imageKey=ANEST%2F93358\" class=\"graphic graphic_movie graphicRef93358 \">movie 1</a>). Both LVOT obstruction and associated MR are exacerbated by decreased preload, decreased afterload, increased contractility, or tachycardia. In addition, because of the underlying LV hypertrophy, LV diastolic dysfunction is common. Thus, maintenance of sinus rhythm is critical to provide adequate LV filling and adequate cardiac output.</p><p>Furthermore, the hypertrophied LV is very susceptible to ischemia and ischemic arrhythmias. Adequate diastolic perfusion pressure (&gt;70 mmHg) is necessary for adequate coronary perfusion of the hypertrophied LV.</p><p>Key hemodynamic goals for patients with HCM include: </p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Heart rate and rhythm</strong> &ndash; Maintain sinus rhythm at a relatively low heart rate to prolong diastole, allowing adequate ventricular filling. Avoid tachycardia because it leads to reduction in ventricular volume, exacerbation of dynamic LVOT obstruction, and increased oxygen demand.</p><p/><p class=\"bulletIndent1\">If atrial fibrillation develops, the loss of the &ldquo;atrial kick&rdquo; provided by sinus rhythm results in reduced LV filling. Treat sudden onset of atrial fibrillation by controlling heart rate with a beta blocker (eg, <a href=\"topic.htm?path=esmolol-drug-information\" class=\"drug drug_general\">esmolol</a>), while maintaining systemic blood pressure (BP) with alpha adrenergic agonists (eg, <a href=\"topic.htm?path=phenylephrine-drug-information\" class=\"drug drug_general\">phenylephrine</a>). </p><p/><p class=\"bulletIndent1\">Perform synchronized cardioversion to restore sinus rhythm if onset of atrial fibrillation is associated with hemodynamic deterioration (eg, hypotension, evidence of cardiogenic shock) or fetal compromise. During cardioversion attempts, BP is maintained with <a href=\"topic.htm?path=phenylephrine-drug-information\" class=\"drug drug_general\">phenylephrine</a>. (See <a href=\"topic.htm?path=atrial-fibrillation-cardioversion-to-sinus-rhythm\" class=\"medical medical_review\">&quot;Atrial fibrillation: Cardioversion to sinus rhythm&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Systemic vascular resistance (SVR) </strong>&ndash; Treat decreases in SVR and blood pressure (BP) immediately with a pure alpha adrenergic agonist (eg, <a href=\"topic.htm?path=phenylephrine-drug-information\" class=\"drug drug_general\">phenylephrine</a>) or with a <a href=\"topic.htm?path=vasopressin-drug-information\" class=\"drug drug_general\">vasopressin</a> infusion (1 to 6 <span class=\"nowrap\">units/hour)</span> (<a href=\"image.htm?imageKey=ANEST%2F96387\" class=\"graphic graphic_table graphicRef96387 \">table 2</a>). Hypotension can lead to a vicious spiral of hemodynamic deterioration, because it exacerbates LVOT obstruction, and will also reduce coronary perfusion pressure and cause myocardial ischemia.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Preload</strong> &ndash; Augment intravascular volume. Adequate preload is critical, since any decrease in ventricular volume can potentially exacerbate LVOT obstruction. Allow intake of clear fluids as per American Society of Anesthesiologist and American Congress of Obstetricians and Gynecologists guidelines to prevent dehydration throughout labor. Intravenous administration of maintenance fluid is initiated at 1 <span class=\"nowrap\">mL/kg</span> per hour and titrated according to clinical assessment of the patient&rsquo;s volume status. </p><p/><p class=\"bulletIndent1\">Two large bore intravenous lines are placed prior to delivery to allow rapid volume replacement, if necessary, in patients with hypertrophic cardiomyopathy (HCM). </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Contractility</strong> &ndash; In contrast to the management of virtually all other cardiac conditions, a decrease in LV contractility is usually beneficial in patients with HCM because LVOT obstruction is reduced. Thus, beta blocking agents (eg, <a href=\"topic.htm?path=esmolol-drug-information\" class=\"drug drug_general\">esmolol</a>, <a href=\"topic.htm?path=metoprolol-drug-information\" class=\"drug drug_general\">metoprolol</a>) and volatile anesthetics are generally used in this condition to decrease dynamic LVOT obstruction.</p><p/><p class=\"bulletIndent1\">Conversely, sympathetic stimulation caused by pain and anxiety, or administration of any inotropic agents that increase contractility (eg, sympathomimetic agents such as <a href=\"topic.htm?path=ephedrine-systemic-drug-information\" class=\"drug drug_general\">ephedrine</a> or catecholamines such as <a href=\"topic.htm?path=epinephrine-adrenaline-drug-information\" class=\"drug drug_general\">epinephrine</a> or <a href=\"topic.htm?path=norepinephrine-noradrenaline-drug-information\" class=\"drug drug_general\">norepinephrine</a>) worsen LVOT obstruction and may result in severe hemodynamic instability. Also, beta-adrenergic receptor agonists, such as <a href=\"topic.htm?path=terbutaline-drug-information\" class=\"drug drug_general\">terbutaline</a>, should be avoided if uterine relaxation is needed because these agents can markedly worsen LVOT obstruction and cause severe arterial hypotension. </p><p/><p class=\"headingAnchor\" id=\"H400568517\"><span class=\"h2\">Anesthetic techniques</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The following considerations apply to patients with HCM and dynamic LVOT obstruction. </p><p/><p>For either labor or surgery, a 5-lead electrocardiogram is placed to monitor for potential myocardial ischemia. An intra-arterial catheter is inserted prior to induction of either regional or general anesthesia, since patients with HCM can decompensate very quickly. In patients with a history of poorly-tolerated tachyarrhythmias, external defibrillator pads are placed on the patient to achieve rapid cardioversion or defibrillation.</p><p class=\"headingAnchor\" id=\"H375331369\"><span class=\"h3\">Neuraxial analgesia for labor</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>We suggest a labor epidural, if feasible. The epidural should be placed early in labor prior to significant catecholamine release from pain. The specific technique used for the test dose should be carefully considered. The analgesic block should be sufficiently dense to avoid any sympathetic stimulation from even mild labor pain. (See <a href=\"topic.htm?path=anesthesia-for-labor-and-delivery-in-high-risk-heart-disease-general-considerations#H77919293\" class=\"medical medical_review\">&quot;Anesthesia for labor and delivery in high-risk heart disease: General considerations&quot;, section on 'Neuraxial analgesia for labor'</a> and <a href=\"topic.htm?path=anesthesia-for-labor-and-delivery-in-high-risk-heart-disease-general-considerations#H1059864016\" class=\"medical medical_review\">&quot;Anesthesia for labor and delivery in high-risk heart disease: General considerations&quot;, section on 'Test dose administration'</a>.) </p><p>In patients with a history of severe LVOT obstruction, an arterial line is inserted early in labor, prior to epidural placement and prior to the onset of any painful contractions.</p><p class=\"headingAnchor\" id=\"H58268916\"><span class=\"h3\">Neuraxial anesthesia for cesarean delivery</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>A very slowly titrated epidural anesthetic or a low-dose combined spinal-epidural (CSE) is reasonable after an intra-arterial catheter has been inserted for continuous monitoring of BP. The specific technique used for the test dose should be carefully considered. (see <a href=\"topic.htm?path=anesthesia-for-labor-and-delivery-in-high-risk-heart-disease-general-considerations#H77919293\" class=\"medical medical_review\">&quot;Anesthesia for labor and delivery in high-risk heart disease: General considerations&quot;, section on 'Neuraxial analgesia for labor'</a> and <a href=\"topic.htm?path=anesthesia-for-labor-and-delivery-in-high-risk-heart-disease-general-considerations#H1059864016\" class=\"medical medical_review\">&quot;Anesthesia for labor and delivery in high-risk heart disease: General considerations&quot;, section on 'Test dose administration'</a>) </p><p>If a low-dose CSE is utilized, then a <a href=\"topic.htm?path=phenylephrine-drug-information\" class=\"drug drug_general\">phenylephrine</a> infusion is initiated at approximately 0.5 <span class=\"nowrap\">mcg/kg</span> per minute at the time of intrathecal injection, and subsequently titrated to keep the BP as close to baseline as possible. If phenylephrine is ineffective, <a href=\"topic.htm?path=vasopressin-drug-information\" class=\"drug drug_general\">vasopressin</a> is administered (<a href=\"image.htm?imageKey=ANEST%2F96387\" class=\"graphic graphic_table graphicRef96387 \">table 2</a>).</p><p>Whether an epidural or sequential CSE technique is utilized, titration of the epidural level can be accompanied by titration of the <a href=\"topic.htm?path=phenylephrine-drug-information\" class=\"drug drug_general\">phenylephrine</a> (or <a href=\"topic.htm?path=vasopressin-drug-information\" class=\"drug drug_general\">vasopressin</a>) infusion. Hypotension resulting from oxytocin should be treated with phenylephrine or vasopressin (<a href=\"image.htm?imageKey=ANEST%2F96387\" class=\"graphic graphic_table graphicRef96387 \">table 2</a>).</p><p>Spinal anesthesia is avoided because of the possibility of rapid sympathectomy, which can cause life-threatening hypotension.</p><p class=\"headingAnchor\" id=\"H375331454\"><span class=\"h3\">General anesthesia for cesarean delivery</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Depth of anesthesia should be adequate to avoid the sympathetic response to laryngoscopy and intubation, as well as subsequent surgical stimulation. Beta blockers (eg, <a href=\"topic.htm?path=esmolol-drug-information\" class=\"drug drug_general\">esmolol</a>, <a href=\"topic.htm?path=labetalol-drug-information\" class=\"drug drug_general\">labetalol</a>, or <a href=\"topic.htm?path=metoprolol-drug-information\" class=\"drug drug_general\">metoprolol</a>) may be used to control heart rate and contractility.</p><p>A reasonable approach is use of a low dose of opioid (eg, 1 to 3 <span class=\"nowrap\">mcg/kg</span> of <a href=\"topic.htm?path=fentanyl-drug-information\" class=\"drug drug_general\">fentanyl</a>), <a href=\"topic.htm?path=lidocaine-drug-information\" class=\"drug drug_general\">lidocaine</a> (eg, 50 to 100 mg) [<a href=\"https://www.uptodate.com/contents/anesthesia-for-labor-and-delivery-in-high-risk-heart-disease-specific-lesions/abstract/16\" class=\"abstract_t\">16</a>], and an induction agent (eg, <a href=\"topic.htm?path=etomidate-drug-information\" class=\"drug drug_general\">etomidate</a> or <a href=\"topic.htm?path=propofol-drug-information\" class=\"drug drug_general\">propofol</a>). High doses of propofol may decrease SVR; thus, if propofol is selected, it is titrated to effect, and hypotension is promptly treated with <a href=\"topic.htm?path=phenylephrine-drug-information\" class=\"drug drug_general\">phenylephrine</a>. Some clinicians use <a href=\"topic.htm?path=remifentanil-drug-information\" class=\"drug drug_general\">remifentanil</a>, an &ldquo;ultra-short&rdquo;-acting opioid, as a supplemental agent during and after induction to provide hemodynamic stability (eg, avoid tachycardia) without risk of causing prolonged neonatal depression [<a href=\"https://www.uptodate.com/contents/anesthesia-for-labor-and-delivery-in-high-risk-heart-disease-specific-lesions/abstract/3,4\" class=\"abstract_t\">3,4</a>]. <a href=\"topic.htm?path=ketamine-drug-information\" class=\"drug drug_general\">Ketamine</a> is contraindicated in patients with HCM because of its sympathomimetic effects. </p><p>Maintenance of anesthesia with the potent inhaled agents is desirable, since reduction in cardiac contractility is beneficial. </p><p>Infusions of <a href=\"topic.htm?path=phenylephrine-drug-information\" class=\"drug drug_general\">phenylephrine</a> and <a href=\"topic.htm?path=vasopressin-drug-information\" class=\"drug drug_general\">vasopressin</a> should be immediately available for treatment of hypotension (<a href=\"image.htm?imageKey=ANEST%2F96387\" class=\"graphic graphic_table graphicRef96387 \">table 2</a>). Avoid vasodilators (eg, <a href=\"topic.htm?path=nitroglycerin-glyceryl-trinitrate-drug-information\" class=\"drug drug_general\">nitroglycerin</a> or <a href=\"topic.htm?path=nitroprusside-drug-information\" class=\"drug drug_general\">nitroprusside</a>) since they decrease preload and SVR, worsening LVOT obstruction. Avoid sympathomimetic agents and catecholamines (eg, <a href=\"topic.htm?path=ephedrine-systemic-drug-information\" class=\"drug drug_general\">ephedrine</a>, <a href=\"topic.htm?path=epinephrine-adrenaline-drug-information\" class=\"drug drug_general\">epinephrine</a>, or <a href=\"topic.htm?path=norepinephrine-noradrenaline-drug-information\" class=\"drug drug_general\">norepinephrine</a>) since they increase contractility and heart rate, worsening LVOT obstruction and ischemia.</p><p>Optimize intravascular volume to maintain BP. During general anesthesia, TEE monitoring is particularly useful in hemodynamically unstable patients with HCM, to assess volume status, LVOT obstruction, LV cavity size and function, mitral regurgitation, and global or regional myocardial ischemia.</p><p>During emergence and tracheal extubation, tachycardia and increases in contractility may lead to LVOT obstruction. Prevent or control these hemodynamic changes by optimizing perioperative analgesia <span class=\"nowrap\">and/or</span> by administering intravenous beta blockers.</p><p class=\"headingAnchor\" id=\"H252769402\"><span class=\"h1\">MARFAN SYNDROME (AORTIC ANEURYSM OR DISSECTION)</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>A summary of key points for management of aortic aneurysm or dissection is provided in the table (<a href=\"image.htm?imageKey=ANEST%2F97443\" class=\"graphic graphic_table graphicRef97443 \">table 10</a>).</p><p class=\"headingAnchor\" id=\"H1073481196\"><span class=\"h2\">Hemodynamic goals and management</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Patients with a dilated ascending aorta and those at risk for aortic dissection (eg, Marfan syndrome) are managed with the hemodynamic goal of reducing aortic wall stress. The risk of aortic rupture or dissection generally increases with larger aortic diameters. Patients with Marfan syndrome and an ascending aorta &ge;40 mm should deliver at an institution where cardiothoracic surgery is available should an aortic emergency occur [<a href=\"https://www.uptodate.com/contents/anesthesia-for-labor-and-delivery-in-high-risk-heart-disease-specific-lesions/abstract/20\" class=\"abstract_t\">20</a>]. (See <a href=\"topic.htm?path=pregnancy-and-marfan-syndrome#H8\" class=\"medical medical_review\">&quot;Pregnancy and Marfan syndrome&quot;, section on 'Delivery'</a>.)</p><p>The goal during labor and delivery in Marfan syndrome is to avoid sympathetic stimulation in order to avoid increases in systemic blood pressure (BP) that result from increased myocardial contractility or systemic vascular resistance (SVR). Most patients are taking beta blockers during pregnancy; use is continued during labor and delivery to prevent surges in BP and cardiac output. </p><p>Key hemodynamic goals for patients with aortic aneurysm or dissection include: </p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Heart rate (HR) </strong>&ndash; Maintain a slow to normal HR.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>SVR </strong>&ndash; Avoid or immediately treat any acute increase in systemic BP with beta blockers (eg, <a href=\"topic.htm?path=esmolol-drug-information\" class=\"drug drug_general\">esmolol</a> or <a href=\"topic.htm?path=labetalol-drug-information\" class=\"drug drug_general\">labetalol</a>) and, if necessary, vasodilators (eg, <a href=\"topic.htm?path=nitroglycerin-glyceryl-trinitrate-drug-information\" class=\"drug drug_general\">nitroglycerin</a> or <a href=\"topic.htm?path=nicardipine-drug-information\" class=\"drug drug_general\">nicardipine</a>). Avoid <a href=\"topic.htm?path=nitroprusside-drug-information\" class=\"drug drug_general\">nitroprusside</a>, as it may cause fetal cyanide toxicity. (See <a href=\"topic.htm?path=management-of-hypertension-in-pregnant-and-postpartum-women#H53705365\" class=\"medical medical_review\">&quot;Management of hypertension in pregnant and postpartum women&quot;, section on 'Nitroprusside'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Preload</strong> &ndash; Maintain normal intravascular volume.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Contractility</strong> &ndash; Avoid sudden increases in contractility. Beta-adrenergic receptor agonists, such as <a href=\"topic.htm?path=terbutaline-drug-information\" class=\"drug drug_general\">terbutaline</a>, should be avoided as a means of causing uterine relaxation, owing to the sympathomimetic side effects of these drugs.</p><p/><p class=\"headingAnchor\" id=\"H374923801\"><span class=\"h2\">Anesthetic techniques</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In patients with aortic aneurysm, inform the peripartum care team that chest or upper back pain during labor, delivery, or the postpartum period may signify aortic dissection and requires immediate attention.</p><p>Monitor electrocardiogram continuously for immediate detection of arrhythmias. An intra-arterial catheter is inserted as early as possible during labor or prior to cesarean delivery, in order to detect and immediately treat any acute increase in BP.</p><p>If aortic dissection has occurred, a central venous catheter is inserted for administration of intravenous vasoactive drugs and to provide large-bore secure intravascular access for volume resuscitation. </p><p class=\"headingAnchor\" id=\"H66801403\"><span class=\"h3\">Neuraxial anesthesia for labor</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>We suggest a labor epidural if feasible. Decreasing the pain and catecholamine release of labor will decrease aortic wall stress. The specific technique used for the test dose should be carefully considered. The analgesic block should be sufficiently dense to avoid any sympathetic stimulation from even mild labor pain. (see <a href=\"topic.htm?path=anesthesia-for-labor-and-delivery-in-high-risk-heart-disease-general-considerations#H77919293\" class=\"medical medical_review\">&quot;Anesthesia for labor and delivery in high-risk heart disease: General considerations&quot;, section on 'Neuraxial analgesia for labor'</a> and <a href=\"topic.htm?path=anesthesia-for-labor-and-delivery-in-high-risk-heart-disease-general-considerations#H1059864016\" class=\"medical medical_review\">&quot;Anesthesia for labor and delivery in high-risk heart disease: General considerations&quot;, section on 'Test dose administration'</a>)</p><p>However, prior to attempting epidural anesthesia, the presence of dural ectasia (<a href=\"image.htm?imageKey=CARD%2F95679\" class=\"graphic graphic_diagnosticimage graphicRef95679 \">image 2</a>) should be considered in patients with Marfan or Loeys Dietz syndrome [<a href=\"https://www.uptodate.com/contents/anesthesia-for-labor-and-delivery-in-high-risk-heart-disease-specific-lesions/abstract/21\" class=\"abstract_t\">21</a>]. (See <a href=\"topic.htm?path=genetics-clinical-features-and-diagnosis-of-marfan-syndrome-and-related-disorders#H15\" class=\"medical medical_review\">&quot;Genetics, clinical features, and diagnosis of Marfan syndrome and related disorders&quot;, section on 'Dural ectasia'</a>.) Although not an absolute contraindication for epidural anesthesia, there is an increased risk of dural puncture or inadequate neuraxial anesthesia [<a href=\"https://www.uptodate.com/contents/anesthesia-for-labor-and-delivery-in-high-risk-heart-disease-specific-lesions/abstract/22\" class=\"abstract_t\">22</a>]. One study suggests that the epidural technique be performed in the lateral decubitus position to decrease the possibility of extension of the ectatic dural sac into the epidural space [<a href=\"https://www.uptodate.com/contents/anesthesia-for-labor-and-delivery-in-high-risk-heart-disease-specific-lesions/abstract/23\" class=\"abstract_t\">23</a>]. </p><p class=\"headingAnchor\" id=\"H375331596\"><span class=\"h3\">Neuraxial anesthesia for cesarean delivery</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Either spinal or epidural anesthesia can be used for anesthesia in patients with an aortic aneurysm if systemic BP is continuously monitored with an intra-arterial catheter. Allowing the BP to drop as much as 20 percent below its baseline after neuraxial interventions is reasonable. However, lower BP may result in uteroplacental insufficiency and fetal distress. Therefore, a <a href=\"topic.htm?path=phenylephrine-drug-information\" class=\"drug drug_general\">phenylephrine</a> infusion should be immediately available at the time of neuraxial block placement and should be titrated to prevent more than a 20 percent decrease in BP.</p><p class=\"headingAnchor\" id=\"H9078723\"><span class=\"h3\">General anesthesia for cesarean delivery</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>If general anesthesia is needed for cesarean delivery, the priority is control of BP throughout the perioperative period, including the immediate preinduction period, induction, maintenance, and emergence. A controlled intravenous induction can be achieved with use of beta blockers (eg, <a href=\"topic.htm?path=esmolol-drug-information\" class=\"drug drug_general\">esmolol</a>), vasodilators (eg, <a href=\"topic.htm?path=nitroglycerin-glyceryl-trinitrate-drug-information\" class=\"drug drug_general\">nitroglycerin</a>), and adequate doses of anesthetic induction agents supplemented with opioids and <a href=\"topic.htm?path=lidocaine-drug-information\" class=\"drug drug_general\">lidocaine</a> to block the sympathetic response to laryngoscopy, intubation, and the subsequent surgical incision. Note that use of nitroglycerin in this setting may lead to uterine relaxation and obstetric hemorrhage.</p><p>A reasonable approach is use of <a href=\"topic.htm?path=propofol-drug-information\" class=\"drug drug_general\">propofol</a> as an induction agent, supplemented with a low dose of an opioid (eg, 1 to 3 <span class=\"nowrap\">mcg/kg</span> of <a href=\"topic.htm?path=fentanyl-drug-information\" class=\"drug drug_general\">fentanyl</a>) and <a href=\"topic.htm?path=lidocaine-drug-information\" class=\"drug drug_general\">lidocaine</a> 50 to 100 mg [<a href=\"https://www.uptodate.com/contents/anesthesia-for-labor-and-delivery-in-high-risk-heart-disease-specific-lesions/abstract/16\" class=\"abstract_t\">16</a>]. Some clinicians use <a href=\"topic.htm?path=remifentanil-drug-information\" class=\"drug drug_general\">remifentanil</a>, an &ldquo;ultra-short&rdquo;-acting opioid, as a supplemental agent during and after induction to provide hemodynamic stability (eg, avoid hypertension) without prolonged neonatal depression [<a href=\"https://www.uptodate.com/contents/anesthesia-for-labor-and-delivery-in-high-risk-heart-disease-specific-lesions/abstract/3,4\" class=\"abstract_t\">3,4</a>]. <a href=\"topic.htm?path=ketamine-drug-information\" class=\"drug drug_general\">Ketamine</a> is contraindicated because of its sympathomimetic effects. </p><p>Maintain adequate depth of anesthesia during subsequent surgical stimulation. Administer beta blockers (eg, <a href=\"topic.htm?path=esmolol-drug-information\" class=\"drug drug_general\">esmolol</a>, <a href=\"topic.htm?path=labetalol-drug-information\" class=\"drug drug_general\">labetalol</a>, or <a href=\"topic.htm?path=metoprolol-drug-information\" class=\"drug drug_general\">metoprolol</a>) as needed to control HR and contractility. Maintain anesthesia with a volatile anesthetic agent titrated to control BP. Administration of vasoactive drugs (eg, esmolol, <a href=\"topic.htm?path=nitroglycerin-glyceryl-trinitrate-drug-information\" class=\"drug drug_general\">nitroglycerin</a>) may be necessary throughout the surgical procedure.</p><p>Optimize intravascular volume to maintain BP. During general anesthesia, transesophageal echocardiography (TEE) monitoring is useful to diagnose hypercontractility or hypovolemia. Also, TEE is useful for localization of any aortic intimal tear and detection of resulting valvular dysfunction (eg, acute aortic regurgitation) or myocardial ischemia.</p><p>During emergence and tracheal extubation, hypertension may lead to aortic dissection. Prevent hypertension by optimizing perioperative analgesia, as well as administering intravenous beta blockers <span class=\"nowrap\">and/or</span> vasodilating agents.</p><p class=\"headingAnchor\" id=\"H437688843\"><span class=\"h2\">Aortic dissection</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>If ascending aortic dissection occurs during pregnancy, labor, or delivery, immediate cardiovascular surgical intervention is warranted because of the high risk of maternal mortality [<a href=\"https://www.uptodate.com/contents/anesthesia-for-labor-and-delivery-in-high-risk-heart-disease-specific-lesions/abstract/20\" class=\"abstract_t\">20</a>]. Management of the fetus depends on the stage of pregnancy and may include cesarean delivery concomitant with cardiac surgery or continuing the pregnancy. (See <a href=\"topic.htm?path=pregnancy-and-marfan-syndrome#H9\" class=\"medical medical_review\">&quot;Pregnancy and Marfan syndrome&quot;, section on 'Aortic dissection'</a> and <a href=\"topic.htm?path=overview-of-acute-aortic-dissection-and-other-acute-aortic-syndromes#H1628662340\" class=\"medical medical_review\">&quot;Overview of acute aortic dissection and other acute aortic syndromes&quot;, section on 'Acute medical management'</a> and <a href=\"topic.htm?path=management-of-acute-aortic-dissection#H722180991\" class=\"medical medical_review\">&quot;Management of acute aortic dissection&quot;, section on 'Acute medical management'</a>.)</p><p>While awaiting surgical intervention, administer pharmacologic therapy to reduce shear stress and BP. Patients are initially treated with an intravenous beta blocker to reduce the heart rate below 60 <span class=\"nowrap\">beats/minute,</span> reduce BP, and reduce the rate of rise in systolic pressure, thus minimizing aortic wall stress. <a href=\"topic.htm?path=esmolol-drug-information\" class=\"drug drug_general\">Esmolol</a> (administered as a bolus loading dose of 500 mcg over one minute and then continued as an infusion starting at 50 <span class=\"nowrap\">mcg/kg</span> per minute up to 300 <span class=\"nowrap\">mcg/kg</span> per minute) has the advantage of a short half-life, enabling titration to effect. The short half-life of esmolol allows rapid offset of its effects in patients intolerant of beta blockers due to asthma or heart failure. Other reasonable beta blocker choices include <a href=\"topic.htm?path=labetalol-drug-information\" class=\"drug drug_general\">labetalol</a> administered as a bolus (initially 20 mg, followed by 20 to 80 mg every 10 minutes to a total dose of 300 mg) or as an infusion at 0.5 to 2 <span class=\"nowrap\">mg/minute,</span> or <a href=\"topic.htm?path=metoprolol-drug-information\" class=\"drug drug_general\">metoprolol</a> 2.5 to 5 mg increments up to a maximum dose of 15 to 20 mg.</p><p>If the systolic BP remains above 100 mmHg after beta blockade, a vasodilator (eg, intravenous <a href=\"topic.htm?path=nicardipine-drug-information\" class=\"drug drug_general\">nicardipine</a> 0.5 to 2 mg bolus followed by an infusion of 5 to 15 <span class=\"nowrap\">mg/hour,</span> or <a href=\"topic.htm?path=nitroglycerin-glyceryl-trinitrate-drug-information\" class=\"drug drug_general\">nitroglycerin</a> infusion at 1 to 4 <span class=\"nowrap\">mcg/kg</span> per minute) may be effective in further lowering BP. <a href=\"topic.htm?path=nitroprusside-drug-information\" class=\"drug drug_general\">Nitroprusside</a> is avoided before delivery because of possible fetal cyanide toxicity.</p><p class=\"headingAnchor\" id=\"H1866708188\"><span class=\"h1\">SOCIETY GUIDELINE LINKS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See <a href=\"topic.htm?path=society-guideline-links-perioperative-cardiovascular-evaluation-and-management\" class=\"medical medical_society_guidelines\">&quot;Society guideline links: Perioperative cardiovascular evaluation and management&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H87110961\"><span class=\"h1\">SUMMARY AND RECOMMENDATIONS</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>General considerations in the anesthetic management of the obstetric patient with acquired or congenital heart disease are discussed separately, including the benefits of epidural analgesia during labor and vaginal delivery, as well as options for neuraxial or general anesthesia for cesarean delivery. (See <a href=\"topic.htm?path=anesthesia-for-labor-and-delivery-in-high-risk-heart-disease-general-considerations\" class=\"medical medical_review\">&quot;Anesthesia for labor and delivery in high-risk heart disease: General considerations&quot;</a>.) </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Anesthetic considerations and hemodynamic management goals for the following specific lesions are shown in tables:</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Aortic stenosis (<a href=\"image.htm?imageKey=ANEST%2F97424\" class=\"graphic graphic_table graphicRef97424 \">table 1</a>) (see <a href=\"#H909976308\" class=\"local\">'Aortic stenosis'</a> above)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Mitral stenosis (<a href=\"image.htm?imageKey=ANEST%2F97435\" class=\"graphic graphic_table graphicRef97435 \">table 3</a>) (see <a href=\"#H909976928\" class=\"local\">'Mitral stenosis'</a> above)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Mitral or aortic regurgitation (<a href=\"image.htm?imageKey=ANEST%2F97437\" class=\"graphic graphic_table graphicRef97437 \">table 4</a>) (see <a href=\"#H855740842\" class=\"local\">'Mitral or aortic regurgitation'</a> above)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Cyanotic congenital heart disease (<a href=\"image.htm?imageKey=ANEST%2F97438\" class=\"graphic graphic_table graphicRef97438 \">table 5</a>) (see <a href=\"#H136552748\" class=\"local\">'Cyanotic congenital heart disease'</a> above)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Ischemic heart disease (<a href=\"image.htm?imageKey=ANEST%2F97439\" class=\"graphic graphic_table graphicRef97439 \">table 6</a>) (see <a href=\"#H235806873\" class=\"local\">'Ischemic heart disease'</a> above)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Dilated cardiomyopathy (<a href=\"image.htm?imageKey=ANEST%2F97440\" class=\"graphic graphic_table graphicRef97440 \">table 8</a>) (see <a href=\"#H252769369\" class=\"local\">'Dilated cardiomyopathies and cardiomyopathy associated with preeclampsia'</a> above)</p><p/><p class=\"bulletIndent3\"><span class=\"glyph\">&#45;</span>Patients with cardiomyopathy associated with preeclampsia are exquisitely sensitive to both endogenous and exogenous catecholamines, and are particularly prone to developing severe hypertension or hypotension. Keep systolic blood pressure &lt;160 mmHg but avoid rapid decreases in systemic vascular resistance. (See <a href=\"#H58268891\" class=\"local\">'Cardiomyopathy associated with preeclampsia'</a> above.)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Hypertrophic cardiomyopathy (<a href=\"image.htm?imageKey=ANEST%2F97442\" class=\"graphic graphic_table graphicRef97442 \">table 9</a>) (see <a href=\"#H327450595\" class=\"local\">'Hypertrophic cardiomyopathy (HCM)'</a> above)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Marfan syndrome (aortic aneurysm or dissection) (<a href=\"image.htm?imageKey=ANEST%2F97443\" class=\"graphic graphic_table graphicRef97443 \">table 10</a>) (see <a href=\"#H252769402\" class=\"local\">'Marfan syndrome (aortic aneurysm or dissection)'</a> above)</p><p/><p class=\"bulletIndent3\"><span class=\"glyph\">&#45;</span>Patients with ascending aortic dissection require immediate cardiovascular surgical intervention, possibly with concomitant cesarean delivery. Administer pharmacologic therapy to reduce aortic shear stress and control blood pressure (eg, beta blockers and vasodilators). (See <a href=\"#H437688843\" class=\"local\">'Aortic dissection'</a> above.) &#160;</p><p/></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/anesthesia-for-labor-and-delivery-in-high-risk-heart-disease-specific-lesions/abstract/1\" class=\"nounderline abstract_t\">American Society of Anesthesiologists Task Force on Obstetric Anesthesia. Practice guidelines for obstetric anesthesia: an updated report by the American Society of Anesthesiologists Task Force on Obstetric Anesthesia. Anesthesiology 2007; 106:843.</a></li><li><a href=\"https://www.uptodate.com/contents/anesthesia-for-labor-and-delivery-in-high-risk-heart-disease-specific-lesions/abstract/2\" class=\"nounderline abstract_t\">Committee on Obstetric Practice, American College of Obstetricians and Gynecologists. ACOG Committee Opinion No. 441: Oral intake during labor. Obstet Gynecol 2009; 114:714. Reaffirmed 2017.</a></li><li><a href=\"https://www.uptodate.com/contents/anesthesia-for-labor-and-delivery-in-high-risk-heart-disease-specific-lesions/abstract/3\" class=\"nounderline abstract_t\">Orme RM, Grange CS, Ainsworth QP, Grebenik CR. General anaesthesia using remifentanil for caesarean section in parturients with critical aortic stenosis: a series of four cases. Int J Obstet Anesth 2004; 13:183.</a></li><li><a href=\"https://www.uptodate.com/contents/anesthesia-for-labor-and-delivery-in-high-risk-heart-disease-specific-lesions/abstract/4\" class=\"nounderline abstract_t\">Ngan Kee WD, Khaw KS, Ma KC, et al. Maternal and neonatal effects of remifentanil at induction of general anesthesia for cesarean delivery: a randomized, double-blind, controlled trial. Anesthesiology 2006; 104:14.</a></li><li><a href=\"https://www.uptodate.com/contents/anesthesia-for-labor-and-delivery-in-high-risk-heart-disease-specific-lesions/abstract/5\" class=\"nounderline abstract_t\">Vongpatanasin W, Brickner ME, Hillis LD, Lange RA. The Eisenmenger syndrome in adults. Ann Intern Med 1998; 128:745.</a></li><li><a href=\"https://www.uptodate.com/contents/anesthesia-for-labor-and-delivery-in-high-risk-heart-disease-specific-lesions/abstract/6\" class=\"nounderline abstract_t\">Robinson S. Pulmonary artery catheters in Eisenmenger's syndrome: many risks, few benefits. Anesthesiology 1983; 58:588.</a></li><li><a href=\"https://www.uptodate.com/contents/anesthesia-for-labor-and-delivery-in-high-risk-heart-disease-specific-lesions/abstract/7\" class=\"nounderline abstract_t\">Dyer RA, Butwick AJ, Carvalho B. Oxytocin for labour and caesarean delivery: implications for the anaesthesiologist. Curr Opin Anaesthesiol 2011; 24:255.</a></li><li><a href=\"https://www.uptodate.com/contents/anesthesia-for-labor-and-delivery-in-high-risk-heart-disease-specific-lesions/abstract/8\" class=\"nounderline abstract_t\">Detry JM. The pathophysiology of myocardial ischaemia. Eur Heart J 1996; 17 Suppl G:48.</a></li><li><a href=\"https://www.uptodate.com/contents/anesthesia-for-labor-and-delivery-in-high-risk-heart-disease-specific-lesions/abstract/9\" class=\"nounderline abstract_t\">Ellis JE, Shah MN, Briller JE, et al. A comparison of methods for the detection of myocardial ischemia during noncardiac surgery: automated ST-segment analysis systems, electrocardiography, and transesophageal echocardiography. Anesth Analg 1992; 75:764.</a></li><li><a href=\"https://www.uptodate.com/contents/anesthesia-for-labor-and-delivery-in-high-risk-heart-disease-specific-lesions/abstract/10\" class=\"nounderline abstract_t\">Leung JM, Voskanian A, Bellows WH, Pastor D. Automated electrocardiograph ST segment trending monitors: accuracy in detecting myocardial ischemia. Anesth Analg 1998; 87:4.</a></li><li><a href=\"https://www.uptodate.com/contents/anesthesia-for-labor-and-delivery-in-high-risk-heart-disease-specific-lesions/abstract/11\" class=\"nounderline abstract_t\">Slogoff S, Keats AS, David Y, Igo SR. Incidence of perioperative myocardial ischemia detected by different electrocardiographic systems. Anesthesiology 1990; 73:1074.</a></li><li><a href=\"https://www.uptodate.com/contents/anesthesia-for-labor-and-delivery-in-high-risk-heart-disease-specific-lesions/abstract/12\" class=\"nounderline abstract_t\">London MJ, Hollenberg M, Wong MG, et al. Intraoperative myocardial ischemia: localization by continuous 12-lead electrocardiography. Anesthesiology 1988; 69:232.</a></li><li><a href=\"https://www.uptodate.com/contents/anesthesia-for-labor-and-delivery-in-high-risk-heart-disease-specific-lesions/abstract/13\" class=\"nounderline abstract_t\">American Society of Anesthesiologists. Practice advisory for the perioperative management of patients with cardiac implantable electronic devices: pacemakers and implantable cardioverter-defibrillators: an updated report by the american society of anesthesiologists task force on perioperative management of patients with cardiac implantable electronic devices. Anesthesiology 2011; 114:247.</a></li><li><a href=\"https://www.uptodate.com/contents/anesthesia-for-labor-and-delivery-in-high-risk-heart-disease-specific-lesions/abstract/14\" class=\"nounderline abstract_t\">Crossley GH, Poole JE, Rozner MA, et al. The Heart Rhythm Society (HRS)/American Society of Anesthesiologists (ASA) Expert Consensus Statement on the perioperative management of patients with implantable defibrillators, pacemakers and arrhythmia monitors: facilities and patient management this document was developed as a joint project with the American Society of Anesthesiologists (ASA), and in collaboration with the American Heart Association (AHA), and the Society of Thoracic Surgeons (STS). Heart Rhythm 2011; 8:1114.</a></li><li><a href=\"https://www.uptodate.com/contents/anesthesia-for-labor-and-delivery-in-high-risk-heart-disease-specific-lesions/abstract/15\" class=\"nounderline abstract_t\">Tihtonen K, K&ouml;&ouml;bi T, Yli-Hankala A, et al. Maternal haemodynamics in pre-eclampsia compared with normal pregnancy during caesarean delivery. BJOG 2006; 113:657.</a></li><li><a href=\"https://www.uptodate.com/contents/anesthesia-for-labor-and-delivery-in-high-risk-heart-disease-specific-lesions/abstract/16\" class=\"nounderline abstract_t\">El-Tahan MR, Warda OM, Diab DG, et al. A randomized study of the effects of perioperative i.v. lidocaine on hemodynamic and hormonal responses for cesarean section. J Anesth 2009; 23:215.</a></li><li><a href=\"https://www.uptodate.com/contents/anesthesia-for-labor-and-delivery-in-high-risk-heart-disease-specific-lesions/abstract/17\" class=\"nounderline abstract_t\">Maron BJ, Braunwald E. Evolution of hypertrophic cardiomyopathy to a contemporary treatable disease. Circulation 2012; 126:1640.</a></li><li><a href=\"https://www.uptodate.com/contents/anesthesia-for-labor-and-delivery-in-high-risk-heart-disease-specific-lesions/abstract/18\" class=\"nounderline abstract_t\">Ho CY. Hypertrophic cardiomyopathy in 2012. Circulation 2012; 125:1432.</a></li><li><a href=\"https://www.uptodate.com/contents/anesthesia-for-labor-and-delivery-in-high-risk-heart-disease-specific-lesions/abstract/19\" class=\"nounderline abstract_t\">Gersh BJ, Maron BJ, Bonow RO, et al. 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2011; 124:2761.</a></li><li><a href=\"https://www.uptodate.com/contents/anesthesia-for-labor-and-delivery-in-high-risk-heart-disease-specific-lesions/abstract/20\" class=\"nounderline abstract_t\">Patel PA, Fernando RJ, Augoustides JG, et al. Acute Type-B Aortic Dissection in Pregnancy: Therapeutic Challenges in a Multidisciplinary Setting. J Cardiothorac Vasc Anesth 2017; 31:2268.</a></li><li><a href=\"https://www.uptodate.com/contents/anesthesia-for-labor-and-delivery-in-high-risk-heart-disease-specific-lesions/abstract/21\" class=\"nounderline abstract_t\">Houston L, Tuuli M, Macones G. Marfan syndrome and aortic dissection in pregnancy. Obstet Gynecol 2011; 117:956.</a></li><li><a href=\"https://www.uptodate.com/contents/anesthesia-for-labor-and-delivery-in-high-risk-heart-disease-specific-lesions/abstract/22\" class=\"nounderline abstract_t\">Lacassie HJ, Millar S, Leithe LG, et al. Dural ectasia: a likely cause of inadequate spinal anaesthesia in two parturients with Marfan's syndrome. Br J Anaesth 2005; 94:500.</a></li><li><a href=\"https://www.uptodate.com/contents/anesthesia-for-labor-and-delivery-in-high-risk-heart-disease-specific-lesions/abstract/23\" class=\"nounderline abstract_t\">Buser RT, Mordecai MM, Brull SJ. Combined spinal-epidural analgesia for labor in a patient with Marfan's syndrome. Int J Obstet Anesth 2007; 16:274.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 93919 Version 22.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H87110961\"><span>SUMMARY &amp; RECOMMENDATIONS</span></a></li><li><a href=\"#H87110730\" id=\"outline-link-H87110730\">INTRODUCTION</a></li><li><a href=\"#H909975868\" id=\"outline-link-H909975868\">MONITORING</a></li><li><a href=\"#H1410255201\" id=\"outline-link-H1410255201\">ANALGESIA AND ANESTHESIA FOR LABOR AND DELIVERY</a><ul><li><a href=\"#H909976159\" id=\"outline-link-H909976159\">Neuraxial analgesia for labor</a></li><li><a href=\"#H1008493904\" id=\"outline-link-H1008493904\">Neuraxial anesthesia for cesarean delivery</a></li><li><a href=\"#H909976649\" id=\"outline-link-H909976649\">General anesthesia for cesarean delivery</a></li></ul></li><li><a href=\"#H909976308\" id=\"outline-link-H909976308\">AORTIC STENOSIS</a><ul><li><a href=\"#H3436077736\" id=\"outline-link-H3436077736\">Pathophysiology and hemodynamic management</a></li><li><a href=\"#H125403349\" id=\"outline-link-H125403349\">Anesthetic techniques</a></li></ul></li><li><a href=\"#H909976928\" id=\"outline-link-H909976928\">MITRAL STENOSIS</a><ul><li><a href=\"#H2311120143\" id=\"outline-link-H2311120143\">Pathophysiology and hemodynamic management</a></li><li><a href=\"#H19381528\" id=\"outline-link-H19381528\">Anesthetic techniques</a><ul><li><a href=\"#H437688507\" id=\"outline-link-H437688507\">- Neuraxial analgesia for labor</a></li><li><a href=\"#H437688515\" id=\"outline-link-H437688515\">- Neuraxial anesthesia for cesarean delivery</a></li><li><a href=\"#H437688534\" id=\"outline-link-H437688534\">- General anesthesia for cesarean delivery</a></li></ul></li><li><a href=\"#H301149167\" id=\"outline-link-H301149167\">Pulmonary edema risk in the post-partum period</a></li></ul></li><li><a href=\"#H855740842\" id=\"outline-link-H855740842\">MITRAL OR AORTIC REGURGITATION</a><ul><li><a href=\"#H1844349936\" id=\"outline-link-H1844349936\">Pathophysiology and hemodynamic management</a></li><li><a href=\"#H136552329\" id=\"outline-link-H136552329\">Anesthetic techniques</a><ul><li><a href=\"#H375330840\" id=\"outline-link-H375330840\">- Neuraxial analgesia for labor</a></li><li><a href=\"#H87110803\" id=\"outline-link-H87110803\">- Neuraxial anesthesia for cesarean delivery</a></li><li><a href=\"#H890497247\" id=\"outline-link-H890497247\">- General anesthesia for cesarean delivery</a></li></ul></li><li><a href=\"#H890497254\" id=\"outline-link-H890497254\">Acute mitral or aortic regurgitation</a></li></ul></li><li><a href=\"#H136552748\" id=\"outline-link-H136552748\">CYANOTIC CONGENITAL HEART DISEASE</a><ul><li><a href=\"#H890691080\" id=\"outline-link-H890691080\">Pathophysiology and hemodynamic management</a></li><li><a href=\"#H235805865\" id=\"outline-link-H235805865\">Anesthetic techniques</a><ul><li><a href=\"#H375330932\" id=\"outline-link-H375330932\">- Neuraxial analgesia for labor</a></li><li><a href=\"#H1005966029\" id=\"outline-link-H1005966029\">- Neuraxial anesthesia for cesarean delivery</a></li><li><a href=\"#H1005966035\" id=\"outline-link-H1005966035\">- General anesthesia for cesarean delivery</a></li></ul></li></ul></li><li><a href=\"#H235806873\" id=\"outline-link-H235806873\">ISCHEMIC HEART DISEASE</a><ul><li><a href=\"#H1159737271\" id=\"outline-link-H1159737271\">Pathophysiology and hemodynamic management</a></li><li><a href=\"#H235806915\" id=\"outline-link-H235806915\">Anesthetic techniques</a><ul><li><a href=\"#H375331076\" id=\"outline-link-H375331076\">- Neuraxial analgesia for labor</a></li><li><a href=\"#H19441235\" id=\"outline-link-H19441235\">- Neuraxial anesthesia for cesarean delivery</a></li><li><a href=\"#H58268596\" id=\"outline-link-H58268596\">- General anesthesia for cesarean delivery</a></li></ul></li></ul></li><li><a href=\"#H252769369\" id=\"outline-link-H252769369\">DILATED CARDIOMYOPATHIES AND CARDIOMYOPATHY ASSOCIATED WITH PREECLAMPSIA</a><ul><li><a href=\"#H1542094901\" id=\"outline-link-H1542094901\">Pathophysiology and hemodynamic management</a></li><li><a href=\"#H252769442\" id=\"outline-link-H252769442\">Anesthetic techniques</a><ul><li><a href=\"#H375331188\" id=\"outline-link-H375331188\">- Neuraxial analgesia for labor</a></li><li><a href=\"#H58268590\" id=\"outline-link-H58268590\">- Neuraxial anesthesia for cesarean delivery</a></li><li><a href=\"#H58268820\" id=\"outline-link-H58268820\">- General anesthesia for cesarean delivery</a></li></ul></li><li><a href=\"#H58268891\" id=\"outline-link-H58268891\">Cardiomyopathy associated with preeclampsia</a><ul><li><a href=\"#H58268809\" id=\"outline-link-H58268809\">- Neuraxial anesthesia for labor</a></li><li><a href=\"#H375331315\" id=\"outline-link-H375331315\">- Neuraxial anesthesia for cesarean delivery</a></li><li><a href=\"#H66801414\" id=\"outline-link-H66801414\">- General anesthesia for cesarean delivery</a></li></ul></li></ul></li><li><a href=\"#H327450595\" id=\"outline-link-H327450595\">HYPERTROPHIC CARDIOMYOPATHY (HCM)</a><ul><li><a href=\"#H498240021\" id=\"outline-link-H498240021\">Pathophysiology and hemodynamic management</a></li><li><a href=\"#H400568517\" id=\"outline-link-H400568517\">Anesthetic techniques</a><ul><li><a href=\"#H375331369\" id=\"outline-link-H375331369\">- Neuraxial analgesia for labor</a></li><li><a href=\"#H58268916\" id=\"outline-link-H58268916\">- Neuraxial anesthesia for cesarean delivery</a></li><li><a href=\"#H375331454\" id=\"outline-link-H375331454\">- General anesthesia for cesarean delivery</a></li></ul></li></ul></li><li><a href=\"#H252769402\" id=\"outline-link-H252769402\">MARFAN SYNDROME (AORTIC ANEURYSM OR DISSECTION)</a><ul><li><a href=\"#H1073481196\" id=\"outline-link-H1073481196\">Hemodynamic goals and management</a></li><li><a href=\"#H374923801\" id=\"outline-link-H374923801\">Anesthetic techniques</a><ul><li><a href=\"#H66801403\" id=\"outline-link-H66801403\">- Neuraxial anesthesia for labor</a></li><li><a href=\"#H375331596\" id=\"outline-link-H375331596\">- Neuraxial anesthesia for cesarean delivery</a></li><li><a href=\"#H9078723\" id=\"outline-link-H9078723\">- General anesthesia for cesarean delivery</a></li></ul></li><li><a href=\"#H437688843\" id=\"outline-link-H437688843\">Aortic dissection</a></li></ul></li><li><a href=\"#H1866708188\" id=\"outline-link-H1866708188\">SOCIETY GUIDELINE LINKS</a></li><li><a href=\"#H87110961\" id=\"outline-link-H87110961\">SUMMARY AND RECOMMENDATIONS</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"ANEST/93919|ALG\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"ALGORITHMS\">ALGORITHMS</a></div><ul><li><a href=\"image.htm?imageKey=ANEST/116023\" class=\"graphic graphic_algorithm\">- Pre- and intraoperative management of patients with a CIED</a></li><li><a href=\"image.htm?imageKey=ANEST/116028\" class=\"graphic graphic_algorithm\">- Postoperative management of patients with a CIED</a></li></ul></li><li><div id=\"ANEST/93919|DiagnosticImage\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"DIAGNOSTIC IMAGES\">DIAGNOSTIC IMAGES</a></div><ul><li><a href=\"image.htm?imageKey=ANEST/102345\" class=\"graphic graphic_diagnosticimage\">- TEE (ME LAX view) showing HCM with SAM</a></li><li><a href=\"image.htm?imageKey=CARD/95679\" class=\"graphic graphic_diagnosticimage\">- Dural ectasia</a></li></ul></li><li><div id=\"ANEST/93919|FIG\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"FIGURES\">FIGURES</a></div><ul><li><a href=\"image.htm?imageKey=ANEST/94174\" class=\"graphic graphic_figure\">- Time spent in diastole</a></li><li><a href=\"image.htm?imageKey=ANEST/109150\" class=\"graphic graphic_figure\">- Placement of transcutaneous pacemaker/defibrillator pads</a></li></ul></li><li><div id=\"ANEST/93919|MOV\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"MOVIES\">MOVIES</a></div><ul><li><a href=\"image.htm?imageKey=ANEST/93358\" class=\"graphic graphic_movie\">- TEE 4C/5C view with LVOT obstruction and associated MR</a></li></ul></li><li><div id=\"ANEST/93919|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=ANEST/97424\" class=\"graphic graphic_table\">- Anesthetic goals aortic stenosis</a></li><li><a href=\"image.htm?imageKey=ANEST/96387\" class=\"graphic graphic_table\">- Vasoactive infusions used in the operating room: Adult dosing</a></li><li><a href=\"image.htm?imageKey=ANEST/97435\" class=\"graphic graphic_table\">- Anesthetic goals for mitral stenosis</a></li><li><a href=\"image.htm?imageKey=ANEST/97437\" class=\"graphic graphic_table\">- Anesthetic goals for AR and MR</a></li><li><a href=\"image.htm?imageKey=ANEST/97438\" class=\"graphic graphic_table\">- Anesthetic goals for CHD</a></li><li><a href=\"image.htm?imageKey=ANEST/97439\" class=\"graphic graphic_table\">- Anesthetic goals for ischemic heart disease</a></li><li><a href=\"image.htm?imageKey=ANEST/91907\" class=\"graphic graphic_table\">- Factors governing O2 supply and demand in myocardial ischemia</a></li><li><a href=\"image.htm?imageKey=ANEST/97440\" class=\"graphic graphic_table\">- Anesthetic goals for dilated cardiomyopathy</a></li><li><a href=\"image.htm?imageKey=ANEST/97442\" class=\"graphic graphic_table\">- Anesthetic goals for HCM</a></li><li><a href=\"image.htm?imageKey=ANEST/97443\" class=\"graphic graphic_table\">- Anesthetic goals for aortic aneurysm</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=acquired-heart-disease-and-pregnancy\" class=\"medical medical_review\">Acquired heart disease and pregnancy</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=acute-aortic-regurgitation-in-adults\" class=\"medical medical_review\">Acute aortic regurgitation in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=acute-mitral-regurgitation-in-adults\" class=\"medical medical_review\">Acute mitral regurgitation in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=anesthesia-for-cesarean-delivery\" class=\"medical medical_review\">Anesthesia for cesarean delivery</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=anesthesia-for-labor-and-delivery-in-high-risk-heart-disease-general-considerations\" class=\"medical medical_review\">Anesthesia for labor and delivery in high-risk heart disease: General considerations</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=anesthesia-for-noncardiac-surgery-in-patients-with-aortic-or-mitral-valve-disease\" class=\"medical medical_review\">Anesthesia for noncardiac surgery in patients with aortic or mitral valve disease</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=anesthesia-for-noncardiac-surgery-in-patients-with-heart-failure\" class=\"medical medical_review\">Anesthesia for noncardiac surgery in patients with heart failure</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=anesthesia-for-noncardiac-surgery-in-patients-with-ischemic-heart-disease\" class=\"medical medical_review\">Anesthesia for noncardiac surgery in patients with ischemic heart disease</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=anesthesia-for-the-patient-with-peripartum-hemorrhage\" class=\"medical medical_review\">Anesthesia for the patient with peripartum hemorrhage</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=atrial-fibrillation-cardioversion-to-sinus-rhythm\" class=\"medical medical_review\">Atrial fibrillation: Cardioversion to sinus rhythm</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=genetics-clinical-features-and-diagnosis-of-marfan-syndrome-and-related-disorders\" class=\"medical medical_review\">Genetics, clinical features, and diagnosis of Marfan syndrome and related disorders</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=hypertrophic-cardiomyopathy-clinical-manifestations-diagnosis-and-evaluation\" class=\"medical medical_review\">Hypertrophic cardiomyopathy: Clinical manifestations, diagnosis, and evaluation</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=intraoperative-transesophageal-echocardiography-for-noncardiac-surgery\" class=\"medical medical_review\">Intraoperative transesophageal echocardiography for noncardiac surgery</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=management-of-eisenmenger-syndrome\" class=\"medical medical_review\">Management of Eisenmenger syndrome</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=management-of-acute-aortic-dissection\" class=\"medical medical_review\">Management of acute aortic dissection</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=management-of-cardiac-risk-for-noncardiac-surgery\" class=\"medical medical_review\">Management of cardiac risk for noncardiac surgery</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=management-of-heart-failure-during-pregnancy\" class=\"medical medical_review\">Management of heart failure during pregnancy</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=management-of-hypertension-in-pregnant-and-postpartum-women\" class=\"medical medical_review\">Management of hypertension in pregnant and postpartum women</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=neuraxial-anesthesia-analgesia-techniques-in-the-patient-receiving-anticoagulant-or-antiplatelet-medication\" class=\"medical medical_review\">Neuraxial anesthesia/analgesia techniques in the patient receiving anticoagulant or antiplatelet medication</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=noncardiac-surgery-in-patients-with-mitral-or-aortic-regurgitation\" class=\"medical medical_review\">Noncardiac surgery in patients with mitral or aortic regurgitation</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-acute-aortic-dissection-and-other-acute-aortic-syndromes\" class=\"medical medical_review\">Overview of acute aortic dissection and other acute aortic syndromes</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=perioperative-management-of-patients-with-a-pacemaker-or-implantable-cardioverter-defibrillator\" class=\"medical medical_review\">Perioperative management of patients with a pacemaker or implantable cardioverter-defibrillator</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=peripartum-cardiomyopathy-etiology-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">Peripartum cardiomyopathy: Etiology, clinical manifestations, and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=postpartum-hemorrhage-medical-and-minimally-invasive-management\" class=\"medical medical_review\">Postpartum hemorrhage: Medical and minimally invasive management</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=pregnancy-and-marfan-syndrome\" class=\"medical medical_review\">Pregnancy and Marfan syndrome</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=pregnancy-and-valve-disease\" class=\"medical medical_review\">Pregnancy and valve disease</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=pregnancy-in-women-with-a-bicuspid-aortic-valve\" class=\"medical medical_review\">Pregnancy in women with a bicuspid aortic valve</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=pregnancy-in-women-with-congenital-heart-disease-general-principles\" class=\"medical medical_review\">Pregnancy in women with congenital heart disease: General principles</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=pregnancy-in-women-with-congenital-heart-disease-specific-lesions\" class=\"medical medical_review\">Pregnancy in women with congenital heart disease: Specific lesions</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=pregnancy-in-women-with-mitral-stenosis\" class=\"medical medical_review\">Pregnancy in women with mitral stenosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=society-guideline-links-perioperative-cardiovascular-evaluation-and-management\" class=\"medical medical_society_guidelines\">Society guideline links: Perioperative cardiovascular evaluation and management</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=use-of-anticoagulants-during-pregnancy-and-postpartum\" class=\"medical medical_review\">Use of anticoagulants during pregnancy and postpartum</a></li></ul></div></div>","javascript":null}